anemia

Search with Google Search with Bing
Information
Disease name
anemia
Disease ID
DOID:2355
Description
"A hematopoietic system disease that is characterized by a decrease in the normal number of red blood cells." [url:http\://en.wikipedia.org/wiki/Anemia, url:http\://www.nhlbi.nih.gov/health/health-topics/topics/anemia/]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT00843882 Active, not recruiting Phase 3 Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia January 29, 2009 September 21, 2024
NCT03071666 Active, not recruiting Phase 2/Phase 3 Vitamin B12 Supplementation During Pregnancy on Cognitive Development March 27, 2017 December 31, 2029
NCT04622241 Active, not recruiting N/A Uganda Housing Modification Study January 29, 2021 July 2023
NCT04582539 Active, not recruiting Phase 1/Phase 2 To Assess the Safety and Tolerability of INCB000928 in Participants With Myelodysplastic Syndromes or Multiple Myeloma August 19, 2021 September 21, 2024
NCT05181436 Active, not recruiting The Prevalence of Malaysian Children Aged ≥ 6 to ≤ 36 Months at Risk of Anaemia July 19, 2022 February 28, 2023
NCT03459287 Active, not recruiting Phase 3 Study to Evaluate the Efficacy & Safety of the INTERCEPT Blood System for RBCs in Complex Cardiac Surgery Patients December 5, 2018 September 30, 2024
NCT05178407 Active, not recruiting N/A Effect of Household Use of Multiple Micronutrient-fortified Bouillon on Micronutrient Status Among Women and Children in Two Districts in the Northern Region of Ghana January 16, 2023 June 2024
NCT04048330 Active, not recruiting Periconceptional Surveillance in India April 7, 2018 December 31, 2024
NCT02048813 Active, not recruiting Phase 3 Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma February 20, 2014 December 31, 2024
NCT03931473 Active, not recruiting N/A Efficacy of Two Dual Active Ingredient Long Lasting Insecticidal Nets for Control of Malaria Transmitted by Pyrethroid Resistant Vectors in Benin June 1, 2020 September 2023
NCT03853304 Active, not recruiting N/A Quadruple Fortified Salt Trial in India October 1, 2023 December 2024
NCT03814395 Active, not recruiting Peking University Birth Cohort in Tongzhou June 28, 2018 August 28, 2025
NCT05682261 Active, not recruiting N/A The Effect of Multiple Micronutrient Supplements in Reducing Anemia in Women of Reproductive Age March 23, 2023 October 2023
NCT05080049 Active, not recruiting Phase 3 Erythropoietin to Improve Critical Care Patient Outcomes January 28, 2022 December 31, 2022
NCT06026618 Active, not recruiting Perioperative Management of Preoperative Anemia in Colorectal Cancer January 1, 2012 January 31, 2024
NCT01702805 Active, not recruiting Phase 3 Transfusion of Prematures Trial December 2012 August 2025
NCT05167734 Active, not recruiting Phase 2 Practical Anemia Bundle for SusTained Blood Recovery November 30, 2021 December 31, 2024
NCT06199362 Active, not recruiting Early Life Anemia and Children's Risk of Neurodevelopmental Disorders: National and Regional Register-based Studies August 15, 2023 December 2024
NCT03810911 Active, not recruiting Phase 2 Mechanisms of EPO-induced Hypertension January 4, 2021 July 31, 2025
NCT05739097 Active, not recruiting Prospective Study on Feto-maternal outcoMe In aNemIc womEn January 1, 2022 February 28, 2025
NCT05585645 Active, not recruiting Phase 3 A Study to Compare Efficacy and Safety of Nanogen's Darbepoetin Alfa With Aranesp® (Amgen) in the Treatment of Anemia in Chronic Kidney Disease Patients on Dialysis (CKD) August 8, 2019 December 31, 2022
NCT01582802 Active, not recruiting Determinants of Neonatal Anemia in Women Carrying Multiples July 2011 December 2023
NCT02934282 Available HBOC-201 Expanded Access Protocol for Life-threatening Anemia for Whom Allogeneic Blood Transfusion is Not an Option
NCT02684474 Available Expanded Access Protocol Using HBOC-201
NCT00072059 Completed Phase 2 Ro 50-3821 in Treating Anemia in Patients Receiving Antineoplastic Therapy for Stage IIIB or Stage IV Non-Small Cell Lung Cancer July 2003 February 2005
NCT00077311 Completed Phase 2 Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer August 2004 April 2009
NCT00077597 Completed Phase 3 A Study of Mircera for the Treatment of Anemia in Dialysis Patients February 2004 June 2006
NCT00077610 Completed Phase 3 A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients February 2004 August 2005
NCT00077623 Completed Phase 3 A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients. March 2004 September 2005
NCT00077766 Completed Phase 3 A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients. March 2004 August 2005
NCT00081471 Completed Phase 3 A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis June 2004 July 2006
NCT00081484 Completed Phase 3 A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients June 2004 March 2006
NCT00086086 Completed Phase 2 Subcutaneous (SC) Darbepoetin Alfa in Subjects With Symptomatic Congestive Heart Failure (CHF) & Anemia August 2003
NCT00090753 Completed Phase 3 A Study of Intravenous or Subcutaneous Methoxy Polyethylene Glycol-Epoetin Beta (RO0503821, Mircera) in Chronic Kidney Disease Patients With Renal Anemia October 2004 December 2009
NCT00091858 Completed Phase 3 Study of Darbepoetin Alfa for the Treatment of Anemia of Cancer April 2004 December 2006
NCT00091910 Completed Phase 3 Research Into the Treatment of Anemia for Critically Ill Patients Admitted to Intensive Care Units (ICU) September 2003 June 2006
NCT00093015 Completed Phase 3 Trial to Reduce Cardiovascular Events With Aranesp® Therapy (TREAT) August 1, 2004 July 1, 2009
NCT00095277 Completed Phase 2 Darbepoetin Alfa Administered Once Every 4 Weeks in the Treatment of Subjects With Anemia of Cancer October 2004
NCT00097747 Completed Phase 1 Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers August 2004 January 2005
NCT00110955 Completed Phase 3 Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy February 2004 April 2005
NCT00111163 Completed N/A Intermittent Preventive Treatment With Antimalarials in Kenyan Infants March 2004 March 2008
NCT00111462 Completed Phase 2 Evaluating Treatment of Anemia in Subjects With Non-Myeloid MalignanciesReceiving Multicycle Chemotherapy
NCT00111995 Completed Phase 4 Evaluating Aranesp® for the Treatment of Anemia in African-American Subjects With Chronic Renal Failure (CRF) Receiving Hemodialysis May 2002
NCT00115167 Completed Phase 3 A Study of Darbepoetin Alfa in Anemic Subjects Not Receiving Chemotherapy Who Have Completed the 20010103 Study August 2004 March 2007
NCT00115921 Completed N/A Evaluation of Home-Based Management of Fever in Urban Ugandan Children July 2005 April 2007
NCT00116493 Completed Phase 3 Severe Anemia Treatment Trials, Pakistan April 2004 May 2007
NCT00117039 Completed Phase 4 A Study to Evaluate the Effectiveness of Aranesp® for Cancer Patients With Anemia January 2004 April 2005
NCT00117065 Completed Phase 4 Study of Transplant Related Anemia Treated With Aranesp® (STRATA)
NCT00117117 Completed Phase 4 A Study to Assess Symptom Burden in Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Aranesp® September 2002 December 2003
NCT00117234 Completed N/A Impact of Darbepoetin Alfa on Exercise Tolerance and Left Ventricular Structure in Subjects With Symptomatic Congestive Heart Failure (CHF) and Anemia September 2002 July 2004
NCT00117247 Completed Phase 1/Phase 2 A Study of Repeat-Dose Subcutaneous Darbepoetin Alfa in Subjects With Congestive Heart Failure and Anemia, and a Single Dose in Healthy Age- and Sex-Matched Control Subjects June 2002 July 2004
NCT00117624 Completed Phase 3 A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With a Non-Myeloid Malignancy December 2002 December 2003
NCT00118027 Completed N/A A New Approach to Deliver Malaria Preventions to Pregnant Women at a Community Level in Uganda May 2003 June 2007
NCT00118638 Completed Phase 3 A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy March 2004 January 2005
NCT00119587 Completed Phase 3 Darbepoetin Alfa Treatment of Anemia in Hemodialysis Subjects August 2002 September 2003
NCT00120237 Completed N/A Misoprostol for the Prevention of Postpartum Hemorrhage in Rural Pakistan July 2005 July 2008
NCT00120679 Completed Phase 2 Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy October 2002 December 2003
NCT00120692 Completed Phase 2 Treatment for Patients Suffering From Anemia Due to Chemotherapy October 2002 December 2003
NCT00120705 Completed Phase 2 Treatment for Anemic Subjects With Non-Myeloid Malignancies Receiving Chemotherapy November 2002 September 2003
NCT00121030 Completed Phase 2 Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to Chemotherapy October 2002 December 2003
NCT00121602 Completed Phase 3 Efficacy Study: Darbepoetin Alfa for the Treatment of Anemia in Patients With Chronic Kidney Disease March 2005 October 2006
NCT00126334 Completed Phase 4 Conservative Versus Liberal Red Cell Transfusion in Myocardial Infarction Trial: The CRIT Pilot April 2003 January 2011
NCT00131716 Completed Phase 3 Prevention of Severe Anaemia in Gambian Children May 2003 May 2005
NCT00136266 Completed Phase 3 Adherence With Iron Sprinkles Among High-Risk Infants March 2005 December 2005
NCT00144131 Completed Phase 2 Flexibility: A Study to Assess the Impact of Darbepoetin Alfa in Subjects withNon-Myeloid Malignancies With Anemia Due to Chemotherapy August 2005
NCT00145652 Completed Phase 3 Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders. December 2003 December 2005
NCT00148421 Completed Phase 3 Study for the Treatment of Anemia in Patients With Non-myeloid Malignancies Receiving Multicycle Chemotherapy.
NCT00153868 Completed Phase 4 A Web-based Study of Quality of Life Benefits Associated Aranesp in Anemic Patients With Cancer October 2003 August 17, 2007
NCT00198835 Completed N/A Evaluation Research of the Nutrition Interventions in the INHP II Areas of CARE India August 2003 July 2007
NCT00202345 Completed Phase 3 Iron Sucrose in Stage 3/4 Kidney Disease August 2004 February 2007
NCT00204334 Completed Phase 4 Effects of Anemia Correction on Vascular and Monocyte Function in Renal Transplant Recipients June 2005 January 2010
NCT00206739 Completed Phase 4 Intermittent Treatment With Sulfadoxine-pyrimethamine for Malaria Control in Infants January 2003 September 2005
NCT00207610 Completed Phase 3 Iron Supplementation Among Low-Income Postpartum Women June 2003 September 2007
NCT00210405 Completed N/A Feasibility and Effectiveness of Distributing Micronutrient Sprinkles to Reduce Prevalence of Anemia March 2005 September 2005
NCT00210587 Completed Phase 3 An Efficacy and Safety Study for Epoetin Alfa (PROCRIT) in Cancer Patients Not Receiving Chemotherapy or Radiation February 2005 December 2005
NCT00210600 Completed Phase 2 Early and Standard Intervention With 120,000 Units of PROCRIT (Epoetin Alfa) Every Three Weeks in Patients Receiving Chemotherapy May 2005 August 2006
NCT00210743 Completed Phase 2 Alternate Dosing - Initiation of Every 2 Week Epoetin Alfa (PROCRIT) in the Treatment of Anemia. May 2004 October 2005
NCT00210756 Completed Phase 2 Pharmacokinetic/ Pharmacodynamic Study of Epoetin Alfa (PROCRIT) in Critically Ill Patients. February 2004 February 2006
NCT00210834 Completed Phase 2 An Efficacy and Safety Study of Epoetin Alfa (PROCRIT) Initiated at 40,000 Units Every Week Versus 80,000 Units Every Two Weeks in Anemic Patients With Cancer Receiving Chemotherapy. May 2004 September 2005
NCT00211055 Completed A Study to Observe the Causes and Treatment of Anemia in Critically Ill Children September 2004 March 2005
NCT00211133 Completed Phase 3 A Study to Evaluate the Impact of Maintaining Hemoglobin Levels Using Epoetin Alfa in Patients With Metastatic Breast Cancer Receiving Chemotherapy June 2000 December 2006
NCT00211146 Completed Phase 3 A Study to Confirm the Safety and Efficacy of Epoetin Alfa (PROCRIT) Administered Perioperatively vs. the Standard of Care in Blood Conservation in Patients Undergoing Major Elective Spinal Surgery (SPINE Study) April 1998 May 2006
NCT00212862 Completed Dosing and Outcomes Study of Erythropoietic Stimulating Therapies in Patients With Chemotherapy Induced Anemia December 2003 July 2009
NCT00212875 Completed Phase 2 A Study of Four Dosing Regimens of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease. Protocol Addendum: Extension Study of Maintenance Therapy of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease. September 2005 February 2007
NCT00213161 Completed N/A Using Iron Supplementation to Decrease Iron Deficiency Anemia in Infants and Young Children in India August 2004 June 2005
NCT00216541 Completed Phase 4 A Study of the Safety and Effectiveness of Epoetin Alfa on Hemoglobin Levels and Blood Transfusions in Cancer Patients Receiving Chemotherapy August 2003 September 2006
NCT00223964 Completed Phase 4 Study of the Efficacy of Two Doses of Ferrlecit in the Treatment of Iron Deficiency in Pediatric Hemodialysis Patients June 2003
NCT00224003 Completed Phase 4 Study of the Safety and Efficacy of Ferrlecit® Maintenance Dosing in Pediatric Hemodialysis Patients April 2003 February 2005
NCT00224068 Completed Phase 4 Effect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer Chemotherapy May 2002 December 2003
NCT00228436 Completed Phase 2 Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney Disease Patients September 2005 November 2007
NCT00228449 Completed Phase 2 Peginesatide for Anemia in Chronic Hemodialysis Patients July 2005 May 2007
NCT00233597 Completed Phase 3 Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Hemodialysis Patients August 2004 March 2007
NCT03346213 Completed CArdio PulmOnary Exercise Testing and IntRAvenous Iron- 'CAPOEIRA-I STUDY' February 2, 2018 October 1, 2018
NCT00001533 Completed Phase 1 Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine September 1996 September 2000
NCT00003138 Completed Phase 3 Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes March 4, 1998 May 2014
NCT00003341 Completed Phase 3 Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy December 1997 September 2003
NCT00003398 Completed Phase 4 Bone Marrow Transplantation in Treating Patients With Hematologic Cancer September 1998 May 2000
NCT00003600 Completed Phase 3 Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy December 1998 January 2010
NCT00004215 Completed Phase 2 Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia August 1999 August 2000
NCT00004914 Completed Phase 2 Exercise Plus Epoetin Alfa in Treating Cancer Patients Who Have Anemia-Related Fatigue January 2000 December 2001
NCT00004917 Completed Phase 3 Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer June 2000 December 2016
NCT00005308 Completed Anemia and Surgery: Indications For Transfusion April 1990 March 1995
NCT00017004 Completed Phase 3 Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia August 2001
NCT00022386 Completed Phase 4 Epoetin Alfa in Treating Chemotherapy-Related Anemia in Women With Stage I, Stage II, or Stage III Breast Cancer April 2004
NCT00031980 Completed Phase 2 Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer March 2002 May 2005
NCT00035607 Completed Phase 2 Chemotherapy Related Anemia December 2001 April 2003
NCT00038064 Completed Phase 3 Anemia in Patients With a Non-Myeloid Malignancy January 2002 April 2004
NCT00046969 Completed Phase 4 Epoetin Beta in Treating Anemia in Patients With Cervical Cancer July 2002 June 2007
NCT00048035 Completed Phase 2 A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia March 2002 June 2005
NCT00048048 Completed Phase 2 A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis. March 2002 November 2004
NCT00049985 Completed Phase 2 Heart Failure and Anemia July 2002
NCT00053001 Completed Phase 2 Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome June 2001 October 2007
NCT00058331 Completed Phase 3 Epoetin Alfa in Treating Anemia in Patients With Solid Tumors June 2003 May 2006
NCT00060398 Completed Phase 3 Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer September 29, 2004
NCT00070382 Completed Phase 3 Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer August 2003
NCT00071032 Completed Phase 3 Safety and Effectiveness of Two Blood Transfusion Strategies in Surgical Patients With Cardiovascular Disease July 2003 May 2009
NCT01244763 Completed Phase 2 Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With Anemia October 29, 2010 June 13, 2012
NCT01309269 Completed Observational Study to Investigate the Long-term Effects of MIRCERA in Clinical Routine September 2010 April 2014
NCT01318551 Completed Phase 1 Single Dose Group Stratified Study in Renal Impaired and Healthy Aged and Gender Matched Subjects March 16, 2011 August 14, 2014
NCT01321099 Completed N/A Iron Absorption From Complementary Food Fortificants (CFFs) and Acceptability of CFFs by Beninese Children May 2011 September 2012
NCT01328704 Completed Evaluate the Change in Iron, Vitamin D, and C-Reactive Protein Level (CRP) in a 12 to 24 Week Period January 2012 March 2013
NCT01332942 Completed Phase 1 Combined Single / Multiple Dose Escalation Study in Patients With Renal Anemia Due to CKD (Chronic Kidney Disease) April 2011 December 2013
NCT01340976 Completed Phase 1 A Phase 1 Study of LY2787106 in Cancer and Anemia January 2010 December 2014
NCT01342640 Completed Phase 4 A Study of Mircera (C.E.R.A.) in Patients With Pre-Dialysis Chronic Renal Anemia July 18, 2011 November 30, 2012
NCT01349699 Completed N/A Effects of Iron Loading and Iron Chelation Therapy on Innate Immunity During Human Endotoxemia February 2010 September 2010
NCT01356589 Completed A Study of MIRCERA for the Intrapetient Variability of Hemoglobin Levels in Patients With Chronic Renal Anemia (RIVAL) September 30, 2010 July 31, 2012
NCT01360502 Completed Safety of Capsule Endoscopy in Patients With Implantable Cardiac Devices December 2009 February 2011
NCT01372137 Completed Phase 1 First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NOX-H94 July 2011 March 2012
NCT01381094 Completed Phase 2 42-Day Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia June 15, 2011 February 16, 2012
NCT01392989 Completed Phase 2 Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders March 2011 March 19, 2017
NCT01394991 Completed Phase 4 A Safety Study of Epoetin Alfa in Patients With Cancer Who Have Chemotherapy-Related Anemia January 2006 September 2009
NCT01404416 Completed Effect of Antenatal Iron-contained Multiple Micronutrient Supplementation, Cesarean Delivery, and CDMR on Child Health May 2011 September 2011
NCT01409967 Completed The Impact of Red Packed Cells Transfusion on the Main Biological Markers to Determine the Etiology of Anemias May 2011 August 2013
NCT01412411 Completed N/A Appropriate Complmentary Feeding Strategies in Infants October 2005 June 2008
NCT01414075 Completed Phase 2 Study of Roxadustat (FG-4592) to Correct Anemia in Newly Initiated Dialysis Participants Not on Erythropoiesis-Stimulating Agent Treatment July 21, 2011 January 10, 2013
NCT01417377 Completed An Observational Study of Mircera (Methoxy Polyethylene Glycol-epoetin Beta) in Anemic Patients With Chronic Kidney Disease (NORM) May 31, 2010 March 31, 2012
NCT01431482 Completed Evaluation of the Composition of Human Milk and Health Outcomes in Children August 2010 June 2012
NCT01432717 Completed Phase 1 Study of ACE-536 in Healthy Postmenopausal Women September 2011 October 2012
NCT01444261 Completed Phase 4 Prevention of Iron Deficiency in Breastfed Infants December 2010 April 2014
NCT01444456 Completed Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia October 2011
NCT01458028 Completed Phase 1 Age and Gender Effects on the Pharmacokinetics of BAY85-3934 September 2011 December 2011
NCT01478971 Completed Phase 3 Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on Dialysis October 2011 February 2013
NCT01488305 Completed N/A Action Against Malnutrition Through Agriculture (AAMA) Plus MNP Study October 2010 June 2012
NCT01514006 Completed Postoperative Anemia and Functional Outcomes After Fast-track Primary Hip Arthroplasty January 2012 August 2013
NCT01518218 Completed Phase 2 Effectiveness of Laying-on-of-hands for Sickle Cell Disease March 2006 December 2009
NCT01553552 Completed Schistosomiasis Effect on Response to Vaccines, Anaemia and Nutritional Status of Children of Northern Senegal October 2011 October 2011
NCT01572506 Completed Phase 1 Mechanisms Accounting for Unexplained Anemia in the Elderly March 29, 2012 July 30, 2015
NCT01580267 Completed Hepcidin and Anemia in Trauma June 2012 April 2014
NCT01586923 Completed Phase 3 RBC Transfusion in Severe Anemia With Lactic Acidosis February 2013 April 2016
NCT01602978 Completed Comparison of Pulse Hemoglobin and Pleth Variability Index February 2010 February 13, 2018
NCT01604083 Completed European Transfusion Practice and Outcome Study April 2013 December 2013
NCT01630889 Completed Phase 2 Open-Label Extension Study for the Long-Term Efficacy and Safety of Roxadustat in Participants With Dialysis and Non-Dialysis Chronic Kidney Disease May 18, 2012 December 12, 2019
NCT01630993 Completed Early Phase 1 Milking the Umbilical Cord at Term Cesarean Birth May 2008 December 2009
NCT01634945 Completed N/A Efficacy of Iron Fortified Complementary Food and IPT of Malaria in Young Children in Côte d'Ivoire April 2012 May 2013
NCT01665378 Completed N/A Impact of Pre-pregnancy Micronutrient Supplementation on Maternal and Child Outcomes October 2011 December 2019
NCT01667380 Completed An Observational Study of Mircera in Patients With Chronic Renal Anemia on Dialysis (CKD Stage V) or Not on Dialysis (CKD Stage III-IV) April 2012 April 2015
NCT01670955 Completed Phase 2 The Safety and Effectiveness of Jobelyn in Pre-operative Management of Anaemia in Gynaecological Patients December 2012 December 2013
NCT01677767 Completed An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Chronic Kidney Disease Patients on Dialysis With Renal Anemia April 30, 2011 September 30, 2013
NCT01681914 Completed Assessment of the Effectiveness of New Clinical Guidelines for Differential Diagnosis and Management of Common HIV/AIDS-related Conditions in Mozambique April 2012 September 2012
NCT01684605 Completed Phase 1 Pharmacokinetics Study of CKD-11101 and NESP After IV Administration in Health Male Volunteers October 12, 2012 January 3, 2013
NCT01685671 Completed Phase 1 Pharmacokinetics Study of CKD-11101 and NESP After SC Administration in Health Male Volunteers October 26, 2012 January 15, 2013
NCT01690455 Completed An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical Practice July 2011 June 2015
NCT01690585 Completed Phase 3 Efficacy of Parenteral Iron Supplementation After Gastrointestinal Bleeding in Subjects Over 65 January 2013 July 2017
NCT01693029 Completed Phase 3 Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa September 2012 March 2015
NCT01695746 Completed An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Stage III-IV Chronic Kidney Disease Patients Not on Dialysis With Renal Anemia August 2011 November 2013
NCT01701310 Completed Phase 4 IVICA: Intravenous Iron in Colorectal Cancer Associated Anaemia April 2012 December 2014
NCT01712308 Completed Phase 2 Sotatercept in Treating Patients With Myeloproliferative Neoplasm-Associated Myelofibrosis or Anemia February 21, 2013 May 24, 2022
NCT01716559 Completed An Observational Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Non-myeloid Malignancy August 2010 March 2012
NCT01725789 Completed Phase 3 Ferinject® Assessment In GastRectomy Patients With Acute Isovolemic Anemia (FAIRY) November 2012 April 2016
NCT01732445 Completed Phase 2 Ruxolitinib Phosphate and Danazol in Treating Anemia in Patients With Myelofibrosis April 2013 August 10, 2017
NCT01733979 Completed N/A Efficacy and Safety of Heme-Iron Polypeptide on Improvement of Anemia February 7, 2012 November 14, 2012
NCT01736683 Completed Phase 2 Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML) November 28, 2012 April 30, 2018
NCT01749514 Completed Phase 2 Study of ACE-536 for the Treatment of Anemia in Patients With Myelodysplastic Syndromes (MDS) January 2013 October 2018
NCT01752413 Completed N/A Iron Depletion and Replacement in Blood Donors December 2012 November 2014
NCT01763242 Completed Phase 4 Study of the Effect of Synchronised Anaemia Management in Chronic Kidney Disease December 2011 December 2012
NCT01763502 Completed N/A The Impact of Cash and Food Transfers Linked to Preschool Enrollment on Child Nutrition and Cognitive Outcomes August 2010
NCT01768351 Completed Phase 4 Paricalcitol Effect on Anemia in CKD October 2010 October 2012
NCT01772420 Completed Phase 2 Phase II Study of Lenalidomide and Eltrombopag in Patients With Symptomatic Anemia October 2012 July 9, 2020
NCT01785407 Completed N/A Using Stable Iron Isotopic Techniques and Serum Hepcidin Profiles to Optimize Iron Supplementation February 2013 June 2013
NCT01795690 Completed Clinical Tumor Anemia Registry (TAR) December 2011 February 2016
NCT01809314 Completed An Observational Study of Epoetin Beta (NeoRecormon) in Participants With Cancer Receiving Chemotherapy March 2008 October 2009
NCT01811342 Completed Continuous Hemoglobin Evaluation November 2012 September 2015
NCT01820182 Completed N/A Prospective Comparison of the Diagnostic Yield of Small Bowel Pillcam SB2 and Capsocam Capsule January 2011 June 2012
NCT01824940 Completed N/A SHINE Sanitation, Hygiene, Infant Nutrition Efficacy Project November 2012 July 31, 2017
NCT01828060 Completed Phase 1/Phase 2 Efficacy of Jobelyn™ Consumption on Hemoglobin Levels in a Borderline Anemic Population April 2013
NCT01902628 Completed OPTIMA: An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Participants With Chronic Kidney Disease Stages 3 and 4 Not on Dialysis July 15, 2013 September 4, 2016
NCT01903148 Completed Anemia Management in Chronic Kidney Disease Not on Dialysis Patients After the European Renal Best Practice (ERBP) Working Group Recommendations October 2011 June 2012
NCT01906489 Completed Phase 2 20-Week Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia July 23, 2013 September 3, 2014
NCT01906515 Completed N/A Impact of SpHb Monitoring on Transfusion February 2012 December 2012
NCT01922479 Completed Phase 4 Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure September 2013 December 2015
NCT01924572 Completed N/A Placental Transfusion in Term Infants: A Pilot Study July 2010 May 2011
NCT01940484 Completed An Observational Study of Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) in Stage V Chronic Kidney Disease Participants on Hemodialysis August 31, 2009 July 31, 2012
NCT01953107 Completed Phase 4 Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates. November 2013 December 2020
NCT01974271 Completed An Observational Study of Hemoglobin Stability in Chronic Kidney Disease Patients on Dialysis Treated With Mircera (Methoxy Polyethylene Glycol-epoetin Beta) January 2014 April 2015
NCT01975818 Completed Phase 2 Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934 October 28, 2013 December 15, 2015
NCT01977547 Completed Phase 3 Age of Blood in Children in Pediatric Intensive Care Units January 2014 December 2018
NCT01985243 Completed N/A Building Capacity for Sustainable Livelihoods and Health November 2013 August 5, 2018
NCT01997892 Completed TRANSFORM - Observational Cohort Study of Darbepoetin Alfa Use in European Union (EU) Hemodialysis Patients Switched From PEG Epoetin Beta August 2012 July 2013
NCT01999582 Completed Phase 2 A Phase 2 Study of Intravenous or Subcutaneous Dosing of Sotatercept (ACE-011) in Patients With End-Stage Kidney Disease on Hemodialysis November 2013 August 2016
NCT02021370 Completed Phase 2 15141 Fixed Dose Correction / naïve and Pre Dialysis (Europe and Asia Pacific) February 10, 2014 September 23, 2015
NCT02021409 Completed Phase 2 Maintenance Treatment of Anemia in Pre-dialysis Subjects With Chronic Kidney Disease on Darbepoetin Treatment Versus BAY85-3934 January 28, 2014 November 23, 2015
NCT02031289 Completed Phase 4 Impact of Preoperative Treatment of Anemia and Iron Deficiency in Cardiac Surgery on Outcome. December 2013 May 2018
NCT02042833 Completed An Observational Study of Patients' Perception of Treatment With Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease Not on Dialysis (PERCEPOLIS) May 2011 June 2012
NCT02044653 Completed Phase 2 Study to Evaluate the Efficacy and Safety of GX-E2 in the Anemic Patients Diagnosed With Chronic Kidney Disease (CKD) April 15, 2014 April 20, 2017
NCT02055482 Completed Phase 2 Long-term Pre-dialysis Extension in Europe and Asia Pacific June 24, 2014 December 12, 2016
NCT02057471 Completed Phase 4 Intravenous Iron: Measuring Response in Anemic Surgical Patients September 2009 March 2012
NCT02064426 Completed Phase 2 Long Term Extension Study for the Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934 March 13, 2014 November 16, 2016
NCT02068755 Completed Blood Products in Cardiac Surgery January 2002 December 2012
NCT02076347 Completed N/A Comparison of Two Pharmacist-led Population Management Approaches to Increase Monitoring of Vitamin B12 and Serum Creatinine Levels for Patients on Metformin February 2014 October 2015
NCT02077751 Completed Phase 1 BioRBC Survival in Adults With Prior Antibody Response to BioRBCs May 2013 December 2019
NCT02079896 Completed Phase 1/Phase 2 Lexaptepid Pegol (NOX-H94) in ESA-hyporesponsive Anemia in Dialysis Patients May 2014 November 2015
NCT02079961 Completed Early Phase 1 Distribution of Fortified Yoghurt in Senegal to Decrease Children's Anemia and Improve Milk Supply January 2013 March 2014
NCT02101567 Completed Phase 4 Carbetocin Versus Oxytocin and Ergometrine for the Prevention of Postpartum Haemorrhage Following Caesarean Section May 2014 April 2015
NCT02101944 Completed Phase 1 Wild-Type Reovirus in Combination With Carfilzomib and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma December 9, 2014 May 7, 2024
NCT02103296 Completed N/A Umbilical Cord Blood Use For Admission Blood Tests of Very Low Birth Weight Preterm Neonates: A Multi-center Randomized Clinical Trial February 2014 July 25, 2021
NCT02118402 Completed N/A Iron and Prebiotics Fortification in Kenyan Infants July 2014 December 2015
NCT02146053 Completed Early Phase 1 Questionnaire to Assess Gastrointestinal Symptoms of Oral Iron. March 2004 December 2004
NCT02161042 Completed The Effect of Blood Transfusion on Endothelial Function August 2011 June 2016
NCT02174627 Completed Phase 3 Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis June 26, 2014 October 4, 2018
NCT02174731 Completed Phase 3 Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease, on Dialysis. July 1, 2014 September 26, 2018
NCT02175888 Completed N/A The Optimization of Bioavailability From Iron Supplements: Study 1 October 2015 January 2016
NCT02176759 Completed N/A Iron Absorption From Rice Fortified With Ferric Pyrophosphate September 2014
NCT02177851 Completed N/A The Optimization of Bioavailability From Iron Supplements: Study 2 June 2015 December 2015
NCT02181348 Completed Phase 1/Phase 2 Effect of Vitamin E Supplementation on Hemoglobin Levels in Healthy Adults November 2008 October 2011
NCT02202967 Completed Phase 3 Misoprostol for Small Bowel Ulcers and Obscure Bleeding Due to Aspirin or Nonsteroidal Antiinflammatory Drugs January 7, 2016 October 11, 2017
NCT02206399 Completed Non-Invasive Hemoglobin Study August 2014 November 2014
NCT02214563 Completed Phase 4 Cholecalciferol Supplementation for Anemia and Mineral and Bone Disorder in Hemodialysis Patients August 2014 December 2016
NCT02222805 Completed N/A Effect of Timing of Umbilical Cord Clamping on Anaemia at 8 and 12 Months and Later Neurodevelopment October 2014 December 11, 2015
NCT02232113 Completed Phase 4 Frequent Dosing of CERA Improves Nutrition and Inflammation in Hemodialysis Patients February 2012 January 2013
NCT02236468 Completed N/A Creating Homestead Agriculture for Nutrition and Gender Equity (CHANGE) in Burkina Faso March 2014 June 2016
NCT02253654 Completed Phase 4 Evaluation of Two Epoetin Alfa Dosing Strategies in Subjects With Chronic Kidney Disease Receiving Hemodialysis April 1, 2015 May 25, 2016
NCT02259166 Completed N/A Enhanced Homestead Food Production Plus+ Program in the Lake Zone, Tanzania June 2014 March 2016
NCT02260193 Completed Phase 2 16-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Participants With End Stage Renal Disease (ESRD) Requiring Chronic Hemodialysis September 10, 2014 July 22, 2015
NCT02276690 Completed N/A Hepcidine and Iron Deficiency in Critically Ill Patients August 2014 September 2017
NCT02278341 Completed Phase 3 Roxadustat in the Treatment of Anemia in End Stage Renal Disease (ESRD) Patients on Stable Dialysis November 21, 2014 July 6, 2018
NCT02300428 Completed Health Economics of the Use of Ferrous Iron Salts in Primary Care in the UK. November 2014 December 2017
NCT02310113 Completed Transfusion and Skeletal Muscle Tissue Oxygenation September 2013 December 2014
NCT02339428 Completed Phase 3 Diclophenac Versus Placebo for Pain Control in Diagnostic Colonoscopy January 2015 October 2016
NCT02341586 Completed N/A Lucky Iron Fish Home Fortification of Iron April 2015 May 2016
NCT02384122 Completed Phase 3 Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias September 2015 May 2023
NCT02390102 Completed Phase 3 Erythropoietin + Iron Therapy for Anemic Patients Undergoing Aortic Valve Replacement June 2012 June 2016
NCT02399449 Completed Phase 4 IV Iron Safety: Evaluation of Iron Species in Healthy Subjects September 15, 2017 April 25, 2019
NCT02439697 Completed N/A A Cohort Study of Conversion From Aranesp® to NESP® for the Treatment of Anemia in Dialysis Patients November 2015 November 2017
NCT02448745 Completed N/A Liberia Insecticide Treated Durable Wall Linings Study: Protocol for a Cluster Randomised Trial (DL) March 1, 2014 April 1, 2017
NCT02465125 Completed Phase 2 The Transfusion Triggers in Vascular Surgery Trial July 15, 2015 January 9, 2017
NCT02466672 Completed The Role and Effect of Anemia in Children With Pneumonia February 2015 January 2016
NCT02481375 Completed N/A Is Iron Deficiency the Cause of Anemia Among Women in Cambodia? July 2015 January 2016
NCT02506868 Completed Phase 3 Safety and Efficacy Study of BCD-066 Compared to Aranesp® for Anemia Treatment in Chronic Kidney Disease Patients August 8, 2015 December 21, 2017
NCT02530515 Completed Phase 2 Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia December 18, 2015 April 30, 2018
NCT02554942 Completed Phase 4 A Study of Epoetin Beta (NeoRecormon) in Participants With Solid Tumors June 2004 September 2005
NCT02564094 Completed Phase 4 A Study of Epoetin Beta (NeoRecormon) in Participants With Solid Tumors or Hematologic Malignancies February 2005 June 2006
NCT02567188 Completed A Study of MIRCERA in Participants With Chronic Kidney Disease Stage 3-4 and Not on Dialysis April 2009 April 2011
NCT02569515 Completed Phase 4 A Study of Epoetin Beta (NeoRecormon) in Predialysis Patients With Renal Anemia October 2004 July 2006
NCT02580773 Completed Phase 3 Therapeutic Anticoagulation Strategy for Acute Chest Syndrome December 16, 2016 September 15, 2021
NCT02593136 Completed N/A Home Fortification of Complementary Foods in Bihar India June 2014 March 2016
NCT02603250 Completed Evaluation of Hemoglobin Measurement Tools for Child Anemia Screening in Rwanda September 2015 December 2015
NCT02610881 Completed N/A Acceptability and Feasibility of Micronutrient Powders Versus Iron Syrup for Anemia Prevention in Young Children December 2015 April 2016
NCT02620943 Completed Dietary Diversity is Associated With Maternal Anemia and Key Prenatal Outcomes in Ethiopia August 2014 March 2015
NCT02628860 Completed Phase 2 Efficacy of Ferric Carboxymaltose (Ferinject®) in Anemic Patients Anticipating Pancreatoduodenectomy January 2014 April 27, 2020
NCT02631980 Completed Phase 3 HepciFer Study: Hepcidin Overexpression After Hepatectomy : Does Iron Supplementation Make Sense ? October 2015 October 2016
NCT02635217 Completed N/A Same Day Bidirectional Endoscopies - Does the Sequence of Procedures or Choice of Insufflator Matter? January 2016 December 2017
NCT02648113 Completed N/A Cost-effectiveness and Cost-utility of Liberal vs Restrictive Red Blood Cell Transfusion Strategies in Patients With Acute Myocardial Infarction and Anaemia. March 23, 2016 September 10, 2020
NCT02648347 Completed Phase 3 Study to Evaluate Vadadustat for the Correction of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease December 2015 July 31, 2020
NCT02651909 Completed Utilization of TEG to Monitor Rivaroxaban Activity April 2016 November 4, 2019
NCT02652806 Completed Phase 3 FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease December 2015 June 14, 2017
NCT02652819 Completed Phase 3 FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease Not on Dialysis December 2015 June 13, 2017
NCT02675140 Completed Phase 4 Effect of Hookworm Elimination and Vitamin A Intervention on Iron Status of Preschool Children in Sichuan, China March 2012 March 2015
NCT02679443 Completed N/A Vitamin Supplementation in NSCLC Patients on Pemetrexed Based Chemotherapy July 2015 December 2016
NCT02680574 Completed Phase 3 Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) February 2016 July 31, 2020
NCT02725255 Completed Phase 2/Phase 3 Design and Clinical Evaluation of a School Meal With Deworming Properties May 2015 March 2016
NCT02734641 Completed Does Increase in Appetite After Iron Treatment Induced by Ghrelin Hormone August 2016 April 17, 2018
NCT02757898 Completed Phase 1 Transfusion of Biotinylated Red Blood Cells January 11, 2017 November 13, 2018
NCT02761642 Completed Phase 2 A Study to Evaluate Efficacy and Safety of Epoetin Beta (NeoRecormon®) in Anemic Participants With Breast Cancer Undergoing Chemotherapy February 29, 2004 March 31, 2007
NCT02767765 Completed Phase 3 A Study of Recombinant Human Erythropoietin Beta (NeoRecormon) in Anemic Cancer Participants Treated With Chemotherapy June 2003 October 2006
NCT02780505 Completed Phase 4 Assessment of the Effect of Vitamin C on Anemia in Patients With Continuous Ambulatory Peritoneal Dialysis November 2011 June 2012
NCT02782806 Completed N/A Spot-Check Noninvasive Pulse CO-Oximeter Validation April 11, 2016 May 19, 2016
NCT02797353 Completed N/A Strengthening Maternal Neonatal and Child Health Services in a Rural District of Pakistan January 2013 August 2016
NCT02808117 Completed Microfinance Institutions as a Platform for Global Health May 2015 November 2016
NCT02817555 Completed Phase 4 Cost Comparison Study of Darbepoetin Versus Epoetin Therapy to Treat Anemia in Hemodialysis Patients September 2010 May 2013
NCT02827266 Completed Phase 3 A Study of Epoetin Beta (NeoRecormon) in Anemic Participants With Diabetes and Chronic Renal Failure Who Are Not on Dialysis October 2005 January 2008
NCT02835937 Completed N/A Red Blood Cell Transfusion in the Ambulatory Setting: Impact on Home Functional Status September 1, 2016 November 10, 2017
NCT02838706 Completed Elderly With Hip Fracture and Perioperative Hemoglobin and Perfusion Index Levels May 2016 December 1, 2016
NCT02840292 Completed Effect of Maternal Hemoglobin on Neurobehavioural Development of Late Preterm Neonates : A Cohort Study June 2014 October 2014
NCT02858505 Completed Phase 2 Impact of One Versus Two Amino Acid Chelated Iron Capsules on Prevention of Iron Deficiency Anemia in Non-anemic Women With Twin Gestations August 2015 July 2016
NCT02860338 Completed COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE January 2009 December 2015
NCT02865850 Completed Phase 3 Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Participants With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD) July 2016 March 30, 2020
NCT02868229 Completed Phase 1/Phase 2 Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of COR-001 September 12, 2016 December 11, 2018
NCT02871128 Completed N/A Evaluation of Natureheme-iron on Iron Absorption Effect and Anti-oxidation Functions July 2015 December 2016
NCT02872376 Completed Clinical Burden of Anemia in Inflammatory Bowel Disease (RIDART1) September 1, 2016 December 31, 2019
NCT02888171 Completed N/A Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency September 2016 March 30, 2019
NCT02892149 Completed Phase 3 Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Dialysis-dependent Chronic Kidney Disease (DD-CKD) August 2016 March 30, 2020
NCT02894294 Completed Evaluation of Seasonal Malaria Chemoprevention in Kita July 2014 June 2015
NCT02909153 Completed Phase 1 Study of Intraperitoneal Triferic in Patients on Chronic Peritoneal Dialysis January 2017 July 2017
NCT02912494 Completed Phase 3 A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD) September 2016 September 2017
NCT02912533 Completed Phase 3 A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD) September 2016 March 2018
NCT02930850 Completed N/A Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation September 2016 October 2016
NCT02948283 Completed Phase 1 Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia September 5, 2017 December 1, 2017
NCT02950142 Completed N/A Evidence-based Laboratory Test Order Sets in Primary Care December 1, 2017 August 1, 2019
NCT02972593 Completed Phase 4 ORthopaedic Trauma Anemia With Conservative Versus Liberal Transfusion March 2014 June 24, 2022
NCT02981407 Completed Phase 3 Myocardial Ischemia and Transfusion April 25, 2017 October 20, 2023
NCT02989311 Completed N/A Effect of Timing of Micronutrient Powder Consumption on Iron Absorption in Infants August 2016 December 2016
NCT02993341 Completed Phase 3 Topical Tranexamic Acid (TXA) in Hip Fractures November 2016
NCT03006718 Completed N/A SCD-PROMIS: A Software Platform to Enhance Self-efficacy and Patient-provider Engagement for Patients With Sickle Cell Pain November 2016 September 2019
NCT03009578 Completed Phase 3 Iron Sucrose Versus Ferrous Bis-glycinate for Treatment of Iron Deficiency Anemia February 1, 2017 June 5, 2018
NCT03010358 Completed Phase 1/Phase 2 Entospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma July 17, 2017 April 29, 2021
NCT03013439 Completed Phase 1 Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®) January 6, 2017 June 4, 2017
NCT03023917 Completed N/A The Study on Umbilical Cord Milking to Prevent and Decrease the Severity of Anemia in Preterms June 30, 2017 December 31, 2019
NCT03054337 Completed Phase 2 Dose-Finding Study of Vadadustat in Japanese Subjects With Anemia Secondary to Non-Dialysis Dependent Chronic Kidney Disease (NDD-CKD) October 2016 August 28, 2017
NCT03054350 Completed Phase 2 Dose-Finding Study of Vadadustat in Japanese Subjects With Anemia Secondary to Dialysis-Dependent Chronic Kidney Disease (DD-CKD) December 2016 January 24, 2018
NCT03060603 Completed Proliferative Effects of Erythropoietin on Human Endometrium February 23, 2017 January 15, 2018
NCT03071497 Completed Non-invasive Diagnostics of Iron Deficiency in Surgical Patients by Measuring Zinc Protoporphyrin-IX March 3, 2017 May 1, 2018
NCT03073590 Completed N/A Improving Anemia Status of Female Garment Workers in Bangladesh: An Evaluation of Pilot Intervention in Four Factories January 27, 2016 June 30, 2017
NCT03120702 Completed N/A Measurement of Total Hemoglobin by Pulse Oximetry in Neonatal Population July 23, 2013 April 20, 2017
NCT03121027 Completed Burden of Anemia Among Ever-married Women in Bangladesh: Does Household Economic Inequality Matter? May 11, 2011 January 18, 2012
NCT03126253 Completed The Burden of Childhood Anemia in Bangladesh: Does Socioeconomic Status Matter? May 11, 2011 January 18, 2012
NCT03128853 Completed N/A Spot-Check Noninvasive Hemoglobin (SpHb) Repeatability and Reproducibility October 31, 2016 November 15, 2016
NCT03194542 Completed Phase 2 A Safety and Efficacy Study to Evaluate Luspatercept in Subjects With Myeloproliferative Neoplasm-associated Myelofibrosis Who Have Anemia With and Without Red Blood Cell-transfusion Dependence November 15, 2017 July 18, 2022
NCT03199235 Completed N/A Iron Fish in Dominican Republic (DR) Children February 20, 2017 October 16, 2018
NCT03211286 Completed Phase 4 Effect of Intravenous Tranexamic Acid on Reduction of Blood Losses in Hip Fracture Patients January 30, 2018 March 8, 2022
NCT03212781 Completed Phase 3 Iron Dextran Versus Oral Iron for Treating Iron Deficiency Anemia in Pregnant Women June 2016 October 2016
NCT03251664 Completed Food Groups Associated With Anaemia in Pregnant Women October 1, 2015 February 20, 2016
NCT03286465 Completed N/A Use of Pediatric Size Phlebotomy Tubes in Adult Critically Ill Patients to Reduce Red Blood Cell Transfusions November 7, 2017 September 30, 2018
NCT03286712 Completed Phase 4 The Effect on Vascular Reactivity Using the Erythropoeitin Alpha on Incident Peritoneal Dialysis Patients October 2015 May 2017
NCT03303066 Completed Phase 2/Phase 3 Efficacy and Safety of FG-4592 for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome (MDS) June 6, 2018 February 8, 2023
NCT03313089 Completed Nutritional Impact of a Project on Food Security and Nutrition in Children Receiving Micronutrient Powders in Colombia July 7, 2017 November 26, 2017
NCT03317210 Completed Phase 4 Intravenous Treatment of Anemia in Pregnancy September 1, 2002 July 31, 2006
NCT03328780 Completed Anemia in Orthopedic Surgery - Determination of Hb December 18, 2017 February 21, 2018
NCT03341338 Completed Genes-in-Action - Hepcidin Regulation of Iron Supplementation September 5, 2016 April 29, 2019
NCT00000587 Completed Phase 2 Erythropoietin for Anemia Due to Zidovudine in Human Immunodeficiency Virus Infection September 1988 January 2005
NCT03350321 Completed Phase 3 A Study of Molidustat for Correction of Renal Anemia in Non-dialysis Subjects December 12, 2017 October 11, 2019
NCT03350347 Completed Phase 3 A Study of Molidustat for Maintenance Treatment of Renal Anemia in Non-dialysis Subjects December 13, 2017 November 28, 2019
NCT03351166 Completed Phase 3 A Study of Molidustat for Correction of Renal Anemia in Dialysis Subjects January 22, 2018 November 20, 2018
NCT03355742 Completed N/A XIENCE 28 Global Study February 9, 2018 April 30, 2020
NCT03377777 Completed The Effect of Anemia in Infancy on the Microbiome and Systemic Metabolism August 1, 2014 November 30, 2014
NCT03378141 Completed N/A Maternal Nutrition Interventions in Uttar Pradesh, India November 15, 2017 December 30, 2020
NCT03407573 Completed N/A Restrictive vs Liberal Transfusion Strategy on Cardiac Injury in Patients Undergoing Surgery for Fractured Neck Of Femur October 1, 2017 June 1, 2019
NCT03418168 Completed Phase 3 A Study of Molidustat for Treatment of Renal Anemia in Peritoneal Dialysis Subjects February 22, 2018 July 29, 2019
NCT03468738 Completed Investigation of the Transfusion Practices in Surgical Patients in Turkey April 2, 2018 February 1, 2019
NCT03470649 Completed N/A Effect of IV Iron Isomaltoside on Postoperative Anemia in Total Knee Arthroplasty Patients March 29, 2018 April 17, 2019
NCT03476707 Completed Association of Anemia With Hospital Costs in Elective Colorectal Surgery January 2010 March 2018
NCT03498755 Completed N/A The Invisible Fishers May 21, 2018 August 17, 2019
NCT03500497 Completed The Change in RetHe - Levels Perioperatively in a Cohort of Colorectal Surgery Patient August 25, 2017 January 2, 2019
NCT03519243 Completed Phase 2 Comparative Study of the Efficacy and Safety of BCD-131 and Mircera in Treatment of Anemia in CKD Patients on Dialysis October 24, 2017 December 10, 2018
NCT03543657 Completed Phase 3 Maintenance Treatment of Renal Anemia in Dialysis Subjects June 23, 2018 December 24, 2019
NCT03552393 Completed Phase 2 Ascertain the Optimal Starting Dose of Mircera Given Subcutaneously for Maintenance Treatment of Anemia in Pediatric Patients With Chronic Kidney Disease on Dialysis or Not Yet on Dialysis. August 3, 2018 July 19, 2021
NCT03558464 Completed N/A Effectiveness Study During the First 1,000 Days in Kenya June 8, 2018 August 31, 2021
NCT03560687 Completed N/A CardioSideral Heart Surgery: Randomized Study on Sucrosomial Iron Supplementation Before Heart Surgery October 15, 2018 July 9, 2020
NCT03560921 Completed Urinary NGAL Acute Kidney Injury After Stored Red Blood Cells Transfusion in Critically Ill Patients. June 2, 2017 December 5, 2017
NCT03586141 Completed N/A Pronto for Patient Blood Management July 22, 2018 November 30, 2018
NCT03596996 Completed N/A Optimizing Iron Status While Minimizing Morbidity in HIV-infected Ugandan Children April 19, 2018 February 10, 2020
NCT03610269 Completed N/A Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation of INVSENSOR00026 August 1, 2018 August 16, 2018
NCT03658876 Completed Phase 4 Predictors of Response to Iron and Erythropoietin Stimulating Agents June 3, 2015 December 31, 2017
NCT03720184 Completed N/A Haemo-autologous Antegrade Repriming (HAR) as Minimum Impact Perfusion Strategy for Cardiopulmonary Bypass August 15, 2018 February 9, 2021
NCT03725384 Completed Phase 3 Daily vs. Every Other Day Oral Iron Supplementation in Patients With Absolute Iron Deficiency Anemia January 4, 2019 January 26, 2022
NCT03749603 Completed N/A A Study Assessing Iron Status and Anemia in Filipino School Children From MIMAROPA Region January 14, 2019 May 20, 2019
NCT03767127 Completed Oxygen Extraction-guided Transfusion in Critically Ill Patients July 1, 2017 December 30, 2018
NCT03776032 Completed Phase 3 A Novel Erythropoiesis Stimulating Protein (NESP; Darbopoetin Alfa) for the Treatment of Anemia in Lung Cancer Patients Receiving Multi-cycle Platinum-Containing Chemotherapy September 14, 1999 February 27, 2002
NCT03776851 Completed Phase 4 Erythropoietin in Hemolytic Uremic Syndrome January 1, 2019 December 30, 2020
NCT03792464 Completed Serum Hepcidin in Pregnant Women and the Association With Pregnancy Outcome April 30, 2019 October 31, 2021
NCT03799627 Completed Phase 2 Study of Vadadustat in Hemodialysis Participants With Anemia Switching From Epoetin Alfa January 31, 2019 July 15, 2020
NCT03803514 Completed Effect of rEPO in FGF23 in ESRD Patients August 15, 2017 October 20, 2019
NCT03815175 Completed N/A XIENCE 28 USA Study February 25, 2019 February 4, 2021
NCT03822884 Completed Phase 1 Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volunteers September 2016 December 2016
NCT03835364 Completed Aptus at Home: Co-design of a Home-based Monitoring System for Anaemia April 13, 2018 January 15, 2021
NCT03835377 Completed N/A Iron-Biofortified Beans Intervention in Mexico January 6, 2010 August 15, 2010
NCT03847662 Completed Scaling up Small-Scale Food Processing to Promote Food Security Among Women Farmers in Rural Vietnam November 3, 2016 June 5, 2018
NCT03847753 Completed Exploring the Comorbidity Between Mental Disorders and General Medical Conditions January 1, 2000 January 31, 2020
NCT03861637 Completed N/A Impact of Full Correction of PTA in Renal Transplant Recipients January 20, 2015 December 20, 2018
NCT03907553 Completed Aging of Hematopoietic Stem Cells - Molecular Architecture of Marrow Dysplasia and Clinical Contribution of Ineffective Hematopoiesis to Frailty in the Elderly July 2003
NCT03916159 Completed N/A Extrauterine Placental Transfusion In Neonatal Resuscitation Of Very Low Birth Weight Infants May 1, 2019 October 24, 2023
NCT03946475 Completed N/A Remaja ASIK and Optimized Food-based Recommendations February 8, 2016 May 10, 2017
NCT03968952 Completed N/A SMARThealth Pregnancy: Feasibility & Acceptability of a Complex Intervention for High-risk Pregnant Women in Rural India. October 1, 2019 November 1, 2020
NCT03978260 Completed Preoperative Anaemia prevaLence In surgiCal patiEnts August 15, 2019 December 31, 2023
NCT04002466 Completed Anemia Etiology Evaluation in Ethiopia January 27, 2019 August 15, 2019
NCT04012957 Completed Phase 3 Desidustat in the Treatment of Anemia in CKD July 20, 2019 August 25, 2021
NCT04017598 Completed Phase 4 Potential Harms of Untargeted Iron Supplementation in Cambodia Where Iron Deficiency is Not the Cause of Anemia December 10, 2019 December 1, 2023
NCT04076969 Completed N/A Integrated Educational Session and Enhancing Compliance Behavior January 1, 2019 August 1, 2019
NCT04078880 Completed N/A Iron Supplementation in Hip/Knee Surgery December 4, 2018 January 1, 2020
NCT04144205 Completed N/A Effect of Arterial Oxygen Partial Pressure on Mixed Venous Oxygen Saturation November 4, 2019 February 11, 2020
NCT04194047 Completed Effects of Red Blood Cells Transfusion on Renal Blood Flow March 1, 2020 September 1, 2022
NCT04212819 Completed N/A Before and After Erythrocyte Suspension Transfusion January 1, 2014 December 31, 2015
NCT04246021 Completed N/A Use of Intravenous Ferric Carboxymaltose in Treatment of Anemia in Cancer Patients Undergoing Chemotherapy June 15, 2016 December 31, 2017
NCT04247178 Completed Non-invasive Identification of Preoperative Anaemia January 31, 2020 March 17, 2020
NCT04309669 Completed Phase 4 Assessment of the eFficacy, the Onset-of-Action and the Safety of Tot'héma® in Adults With Moderate Iron Deficiency Anaemia November 12, 2020 October 6, 2023
NCT04313153 Completed Phase 3 Trial Evaluating the Efficacy and Safety of Oral Vadadustat Once Daily (QD) and Three Times Weekly (TIW) for the Maintenance Treatment of Anemia in Hemodialysis Subjects Converting From Erythropoiesis-Stimulating Agents (ESAs) May 27, 2020 June 22, 2022
NCT04377061 Completed Anemia in Non-celiac Wheat Sensitivity January 1, 2020 January 1, 2022
NCT04391517 Completed N/A SpHb Perioperatively January 1, 2020 December 1, 2021
NCT04404751 Completed N/A Quadruple Fortified Salt Clinical Trial August 23, 2019 December 31, 2020
NCT04414527 Completed N/A Effects of Video-based Health Education on Maternal and Child Health in Ethiopia March 13, 2020 July 31, 2021
NCT04450381 Completed N/A Noninvasive Hemoglobin Testing, Prospective Blood Donors June 23, 2020 July 7, 2020
NCT04490863 Completed N/A Noninvasive Hemoglobin Repeatability and Reproducibility in a Blood Donation Setting July 16, 2020 August 20, 2020
NCT04506125 Completed N/A Liberal Versus Restrictive Transfusion Threshold in Oncologic surgerY March 18, 2021 August 29, 2022
NCT04561635 Completed N/A Effects of Multiple-micronutrients Supplementation on Growth and Iron Status of Indigenous Children in Malaysia September 1, 2017 April 30, 2019
NCT04623918 Completed N/A Iron-Biofortified Rice Intervention in the Philippines June 1, 2002 December 31, 2003
NCT04628897 Completed Physical Activity and the Home Environment in Preschool-aged Children in Urban Bangladesh September 17, 2017 December 9, 2017
NCT04631679 Completed Investigation of the Wash-out Effect of Intravenous Iron by Cell Savers (WASH-OUT) November 8, 2019 April 29, 2021
NCT04632771 Completed Nutritional Status and Bouillon Use in Northern Ghana October 19, 2020 February 28, 2022
NCT04657640 Completed Phase 3 School-Based Assessment of Micronutrient Interventions in Adolescents in Burkina Faso December 11, 2020 April 30, 2024
NCT04661865 Completed N/A Effect of Health Information Package Program on Knowledge and Compliance Among Pregnant Women With Anemia January 1, 2021 May 31, 2021
NCT04694898 Completed N/A Sustainable Undernutrition Reduction in Ethiopia December 28, 2020 March 13, 2021
NCT04744181 Completed Patient Blood Management In CARdiac sUrgical patientS January 18, 2021 January 31, 2022
NCT04779840 Completed Retrospective Study on the Incidence and Management of Anemia in Oncology May 20, 2020 January 20, 2021
NCT04788303 Completed N/A Meals, Education, and Gardens for In-School Adolescents (MEGA) Project January 24, 2022 September 30, 2022
NCT04820465 Completed Anemia in Older Adults July 2015 September 2015
NCT04858087 Completed Malawi International Center of Excellence in Malaria Research School-based Cohort March 24, 2015 November 13, 2015
NCT04880499 Completed N/A Iron and Vitamin Supplementation in Hip/Knee Surgery April 21, 2021 July 8, 2022
NCT04939558 Completed Cardiorespiratory Diagnostic Study June 2, 2021 November 30, 2022
NCT04948424 Completed A Retrospective Observational Study to Describe Anaemia Management, Burden of Disease and Outcomes in Chinese Patients on Peritoneal Dialysis Using a Clinical Database January 1, 2022 August 31, 2022
NCT04974073 Completed Phase 3 Development of PHY606 as Adjunct Therapy for Anemia Patients August 22, 2017 November 18, 2019
NCT04980911 Completed Iron Deficiency and Anemia in Cardiac Surgery April 12, 2021 March 18, 2022
NCT04983654 Completed N/A Functional and Mechanistic Characterization of Limb Ulcers in Patients With Sickle Cell Disease February 9, 2022 October 3, 2023
NCT05033483 Completed N/A Do Iron Supplements Impact the Gut Microbiome of Women of Reproductive Age? August 31, 2021 January 1, 2022
NCT05059314 Completed N/A Effects Of Moderate Physical Activity On Hb, Physical Fitness And Psychological Well Being In Females April 29, 2021 December 30, 2021
NCT05059457 Completed Comparison of Blood Sampling Methods for Hemoglobin Measurement August 23, 2021 September 26, 2021
NCT05098249 Completed Phase 4 Ferric Carboxymaltose With or Without Phosphate Substitution for the Treatment of Iron Deficiency or Iron Deficiency Anemia November 11, 2021 May 23, 2023
NCT05104554 Completed N/A School-Based Assessment of Micronutrient Interventions in Adolescents (SAMIA) in Zanzibar March 10, 2022 December 30, 2023
NCT05185661 Completed N/A Impact of eHealth Education to Reduce Anemia Among School-going Adolescent Girls in Rural Bangladesh May 22, 2022 January 30, 2024
NCT05226416 Completed Analysis of Health Status of Сomorbid Adult Patients With COVID-19 Hospitalised in Fourth Wave of SARS-CoV-2 Infection February 21, 2022 April 21, 2023
NCT05254717 Completed N/A Effect of Soaking Complementary Foods Flour on Hemoglobin Concentration, Anthropometric Deficits and Episode of Diarrheal, Cough and Fever Morbidities November 1, 2021 May 15, 2022
NCT05355324 Completed Risk Factor for Readmission and Death of Lower Respiratory Infections in Older Adults March 1, 2016 December 31, 2021
NCT05374837 Completed N/A Mobile Messaging for Improved Nutrition June 10, 2022 December 15, 2022
NCT05455073 Completed N/A Evaluation of School-based Nutrition Intervention for Adolescents in Bangladesh July 31, 2019 February 28, 2022
NCT05585268 Completed N/A Electronic Decision Support for Deprescribing in Patients on Hemodialysis October 3, 2022 December 1, 2022
NCT05626647 Completed Etiology of Anemia Among Preschool Children in Ethiopia November 1, 2021 September 4, 2022
NCT05669209 Completed Causes of Anemia Among Women of Reproductive Age December 16, 2022 February 3, 2023
NCT05788172 Completed Measuring Menstrual Iron Loss Using the Iron Isotope Dilution Technique March 1, 2023 August 30, 2023
NCT05833178 Completed The Effect of Blood Tests Performed Within the Routine Protocol in the Surgical Intensive Care Unit on Hemoglobin Levels April 1, 2023 May 31, 2023
NCT05922696 Completed Phase 2/Phase 3 Cholecalciferol Supplementation in Hemodialysis Patients May 15, 2022 January 26, 2023
NCT05951192 Completed Phase 4 A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease July 1, 2023 February 14, 2024
NCT06009575 Completed Phase 3 Local Culture-Based Nutrition Education Intervention on Iron Supplement Tablets (IST) Consumption Compliance in Female Adolescents at Ogan Komering Ilir Regency: A Quasi-Experimental Protocol Study July 1, 2021 January 31, 2022
NCT06176105 Completed Mortality After Transfusion of Ever-pregnant Donor Red Blood Cells October 1, 2019 October 1, 2020
NCT06227819 Completed BVA-200 vs BVA-100 Validation Study May 23, 2023 November 30, 2023
NCT00236938 Completed Phase 3 Efficacy and Safety of Venofer (Iron Sucrose Injection USP) in Patients Receiving Peritoneal Dialysis July 2002 October 2004
NCT00236951 Completed Phase 3 Intravenous (IV) Iron vs. No Iron as the Treatment of Anemia in Cancer Patients Undergoing Chemotherapy and Erythropoietin Therapy February 2003 December 2005
NCT00236964 Completed Phase 3 Comparison of Oral Iron With IV Iron in Patients With Anemia of Chronic Renal Failure Not on Dialysis February 2001 May 2002
NCT00236977 Completed Phase 3 Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia August 2003 October 2004
NCT00239239 Completed Phase 2 Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies August 2005 March 2007
NCT00239616 Completed Phase 4 Pharmacokinetic Study of Intravenous Iron Sucrose in Adolescents on Hemodialysis or Peritoneal Dialysis Receiving Epoetin June 2002 November 2003
NCT00239642 Completed Phase 4 Safety and Efficacy of Iron Sucrose in Children July 2005 April 2010
NCT00245895 Completed Phase 2 Study of Aranesp to Treat Anemia in Prostate Cancer Patients. April 2003 February 2005
NCT00255424 Completed Phase 3 Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients May 2004 August 2006
NCT00255437 Completed Phase 3 Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients June 2004 November 2006
NCT00255450 Completed Phase 3 A Crossover Safety Study of Ferumoxytol Versus Placebo January 2005 August 2006
NCT00255749 Completed Phase 2 Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer August 2005
NCT00261274 Completed Phase 1 Safety Study of ECO Conversion System For Red Blood Cells. November 2005
NCT00261521 Completed Phase 3 A Study of the Safety and Efficacy of Long-term Correction of Anemia With Epoetin Alfa in Early Hemodialysis Patients February 2000 May 2003
NCT00261677 Completed Phase 3 A Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) or Placebo on Anemia and Quality of Life in Children With Cancer Undergoing Chemotherapy August 2000 October 2003
NCT00264095 Completed An Observational Study of Blood Management Techniques in Oncology Surgical Treatment July 2004 February 2006
NCT00264108 Completed Cost-effectiveness Study of Epoetin Alfa and Darbepoetin Alfa in Adult Patients With Cancer Who Have Anemia June 2005 February 2011
NCT00266617 Completed Phase 2 A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in Patients With Anemia as a Result of Advanced Cancer and Treatment With Aggressive Chemotherapy June 1990
NCT00269945 Completed Phase 2 A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their Disease January 1989
NCT00269958 Completed Phase 2 A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo to Reduce the Need for Blood Transfusions and Reduce the Occurrence of Severe Anemia During the Time Period Surrounding Total Hip Replacement Surgery December 1991
NCT00269984 Completed Phase 2 A Study to Determine the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Patients With Persistent Anemia Caused by Advanced Cancer June 1990
NCT00269997 Completed Phase 2 A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Patients With Persistent Anemia as a Result of Cancer Treatment With Cisplatin, a Platinum-containing Chemotherapy Drug July 1990
NCT00270010 Completed Phase 2 A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their Disease August 1989
NCT00270036 Completed Phase 2 A Study to Determine the Safety of Epoetin Alfa and Whether Epoetin Alfa Can Reduce the Need for Blood Transfusions in Patients After Major Orthopedic Surgery. April 1991 October 1991
NCT00270049 Completed Phase 2 Epoetin Alfa for the Treatment of Anemia Resulting From Chronic Lymphocytic Leukemia November 1990 January 1994
NCT00270062 Completed Phase 3 A Study to Evaluate the Safety of Epoetin Alfa and Its Effectiveness in Facilitating the Presurgical Collection of Blood From Anemic Patients for Possible Self-transfusion During and After Scheduled Joint Surgery. May 1989 July 1991
NCT00270088 Completed Phase 3 A Study to Determine Whether Epoetin Alfa Can Reduce the Need for Blood Transfusions in Patients During the Period of Time Around Major Orthopedic Surgery. April 1993 August 1994
NCT00270101 Completed Phase 3 The Effect of Epoetin Alfa on the Anemia of Patients With Multiple Myeloma January 1995 September 1996
NCT00270114 Completed Phase 2/Phase 3 A Study of the Safety and Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Patients Who Are Undergoing Orthopedic Surgery and Who Have Low Hematocrit Levels (the Percent of Red Blood Cells in Whole Blood) March 1991
NCT00270127 Completed Phase 3 Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy August 1996 September 1998
NCT00270140 Completed Phase 3 A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Facilitating the Presurgical Collection of Blood to be Used for Self-donation During Surgery on the Spine, Hip, or Knee. September 1989 August 1991
NCT00270166 Completed Phase 3 The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy February 1995 May 1998
NCT00270179 Completed Phase 3 A Study to Evaluate the Effectiveness and Safety of Epoetin Alfa During the Period When One is Donating One's Own Blood Before Surgery. May 1988
NCT00270270 Completed Phase 2 A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) Therapy July 1989
NCT00270283 Completed Phase 2 A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in Patients With Acquired Immunodeficiency Syndrome (AIDS) Who Are Receiving Zidovudine (AZT) Therapy July 1988 April 1990
NCT00281892 Completed Phase 3 Fludarabine and Darbepoetin Alfa in Treating Older Patients With Chronic Lymphocytic Leukemia September 2004 October 2010
NCT00283465 Completed Phase 4 A Study of the Effectiveness and Safety of Treatment With Epoetin Alfa on Hemoglobin Levels, Red Blood Cell Transfusions, and Quality of Life in Patients With Cancer Receiving Platinum-containing Chemotherapy November 1999 April 2004
NCT00285662 Completed N/A Intermittent Preventive Treatment (IPTi) for the Prevention of Malaria and Anaemia in PNG Infants June 2006 May 2010
NCT00286182 Completed Phase 2 Anemia in Heart Failure With a Preserved Ejection Fraction (HFPEF) July 2007 November 2012
NCT00294203 Completed Phase 1 Pilot Study of Epoetin Alfa for Patients Having Abdominal or Pelvic Surgery for Cancer February 2006 December 2008
NCT00303329 Completed Phase 2 Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients March 2004 October 2008
NCT00307814 Completed Phase 2 A Study to Evaluate PROCRIT (Epoetin Alfa) for Maintenance Phase Treatment of Patients With Anemia Due to Chronic Kidney Disease (PROMPT) January 2002 January 2004
NCT00313716 Completed Phase 2/Phase 3 Effects of Erythropoietin on Cerebral Vascular Dysfunction and Anemia in Traumatic Brain Injury April 2006 March 2013
NCT00314795 Completed Phase 2 Efficacy and Safety of Peginesatide (AF37702) in the Treatment of Anemia in Participants With Chronic Kidney Disease April 6, 2006 October 31, 2016
NCT00315432 Completed Phase 2 NATURAL HISTORY-Hepatitis C Virus/ Human Immunodeficiency Virus Coinfection September 2000 November 2003
NCT00315484 Completed Phase 4 Hematologic Response of Epoetin Alfa (PROCRIT) Versus Darbepoetin Alfa (ARANESP) in Chemotherapy Induced Anemia February 2003 October 2004
NCT00317226 Completed Phase 3 Long Term Safety Study of (VIT45) Extension Study: Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease June 2005 September 2007
NCT00317239 Completed Phase 3 VIT45 Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease May 2005 August 2007
NCT00317902 Completed Phase 4 An Open-Label Study to Evaluate the Effect of Every Other Week PROCRIT� (Epoetin Alfa) Dosing (40,000-60,000 Units) On Maintaining Quality of Life and Target Hemoglobin Levels in Anemic HIV-Infected Patients (CHAMPS II) October 2002 May 2004
NCT00318227 Completed N/A Randomized Trial of a Liberal Versus a Restrictive Transfusion Strategy in Elderly Cardiac Surgery Patients June 21, 2004 February 23, 2010
NCT00318812 Completed Phase 2/Phase 3 Heme Iron Polypeptide for Iron Deficiency Anemia in Chronic Renal Failure May 2007 December 2011
NCT00321919 Completed Phase 3 A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia July 2000 December 2004
NCT00327535 Completed Phase 2 A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy. May 2006 May 2007
NCT00328549 Completed Phase 2 A Study to Evaluate the Erythropoietic Response in Hepatitis C Virus (HCV) Patients Receiving Combination Ribavirin (RBV)/Interferon (IFN) Therapy or RBV/PEG IFN (NATURAL HISTORY-HCV) October 2001 December 2002
NCT00335023 Completed Phase 4 Well Being of Obstetric Patients on Minimal Blood Transfusions May 2004
NCT00337935 Completed Phase 2 A Study of the Use of PROCRIT (Epoetin Alfa) for the Treatment of Anemia in People With Chronic Kidney Disease Who Live in Long-term Care Facilities. July 2006 July 2009
NCT00337948 Completed Phase 2 An Efficacy and Safety Study of PROCRIT (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Week or Every Four Weeks February 2003 February 2005
NCT00338234 Completed Observational Study of Iron Metabolism in Anemia in ICU and Post-Operative Patients June 2006 December 2007
NCT00338299 Completed Phase 2 Alternate Dosing of PROCRIT (Epoetin Alfa) in Patients With Cancer and Chemotherapy Induced Anemia August 2003 April 2004
NCT00338416 Completed Phase 2 An Efficacy and Safety Study of PROCRIT (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Three Weeks March 2003 January 2005
NCT00341055 Completed Phase 3 A Study to Evaluate the Hematologic Response Rate (the Rate at Which the Hemoglobin Level Rises) of PROCRIT (Epoetin Alfa) Given at a Dose of 80,000 Units Once Weekly to Cancer Patients With Anemia Who Are Receiving Chemotherapy. June 2003 May 2004
NCT00344409 Completed Phase 3 A Double-blind Study of KRN321 for the Treatment of Anemia in Cancer Patients March 2006
NCT00354341 Completed Phase 3 (ACORD Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Early Diabetic Nephropathy September 2002 July 2005
NCT00358215 Completed Phase 3 RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial June 1, 2006 October 11, 2012
NCT00359840 Completed Phase 2 A Dose Finding Study of KRN321(Darbepoetin Alfa) for the Treatment of Anemia in Subjects With Solid Tumor July 2006
NCT00360347 Completed Phase 1/Phase 2 A Study of Mircera in Anemic Patients With Multiple Myeloma November 29, 2001 April 29, 2003
NCT00360425 Completed Phase 1 A Study of the Electrocardiogram Effects and Pharmacokinetics of Ferumoxytol in Healthy Men and Women May 2006 August 2006
NCT00364260 Completed Phase 3 A Safety and Efficacy Study for Epoetin Alfa in Pre-dialysis Subjects. December 1997 August 2003
NCT00364832 Completed Phase 2 A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia. October 2001 July 2005
NCT00367380 Completed Phase 2 Evaluation of Reproducibility of a Sporozoite Challenge Model for Plasmodium Vivax in Human Volunteers December 2006 March 2007
NCT00369005 Completed N/A Liberal Versus Restrictive Transfusion Guidelines for Preterm Infants December 1992 June 1999
NCT00377481 Completed Phase 4 COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia. September 2006 June 2007
NCT00382044 Completed Audit of the Effect of Changing From IV to SC Administration of ESA's in Haemodialysis Patients September 2006 April 2008
NCT00388336 Completed Phase 2 PROCRIT (Epoetin Alfa) 60,000 Units Administered Once Every Two Weeks in Anemic Cancer Patients Who Are Not Receiving Chemotherapy or Radiation Therapy February 2004 March 2005
NCT00392418 Completed N/A Flexible Administration of Sprinkles® in Infants and Young Children in Rural Bangladesh. May 2004 March 2005
NCT00394953 Completed Phase 3 A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients December 2006 November 2008
NCT00395993 Completed Phase 3 Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding May 2005 June 2006
NCT00396123 Completed Effects Of Darbepoetin On Vascular Repair Mechanisms In Kidney Disease The DARBEPC Study November 2006 July 25, 2008
NCT00396292 Completed Phase 3 Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in Subjects Who Display Postpartum Anemia February 2005 February 2006
NCT00398749 Completed Survey on the Treatment of Anemia Using Recombinant Human Erythropoietin 2 (STAR-2) October 2005 November 2009
NCT00399269 Completed Phase 3 Efficacy & Safety Study of Recombinant Human Erythropoietin -Alpha, in Patients With Anemia of Chronic Renal Failure December 2006 June 2007
NCT00400686 Completed N/A Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple Myeloma September 2003 August 2013
NCT00401544 Completed Phase 2 Darbepoetin Alfa With or Without Intravenous (IV) Iron December 2006 March 2008
NCT00401869 Completed Phase 4 The Effect of PROCRIT (Epoetin Alfa) on Postoperative Vigor and Handgrip Strength (VIGOR Study) February 1999 December 2001
NCT00413101 Completed Phase 4 A Study of NeoRecormon (Epoetin Beta) in Patients With End Stage Renal Disease. March 2008
NCT00413894 Completed Phase 3 A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients. March 2007 October 2008
NCT00416624 Completed Phase 2 Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy May 2007 June 2009
NCT00431496 Completed Phase 4 A Study of Cinacalcet to Improve Achievement of National Kidney Foundation Kidney Disease Outcomes Quality Initiative (K/DOQI) Targets in Patients With End Stage Renal Disease (ESRD) September 2006 October 2009
NCT00434330 Completed Phase 2 Peginesatide for Maintenance Treatment of Anemia in Participants on Hemodialysis December 2006 April 2008
NCT00437723 Completed Phase 4 A Study of NeoRecormon in Patients With Chronic Kidney Disease. April 2008
NCT00437866 Completed Hepcidin in Anemic Chronic Heart Failure (CHF) Patients January 2007 July 2010
NCT00440466 Completed Phase 3 PROCRIT Extended Dosing For Maintenance of Hemoglobin in Pre-Dialysis CKD Patients July 2007 March 2009
NCT00440557 Completed Phase 3 An Efficacy and Safety Study of Epoetin Alfa for Initiation and Maintenance Treatment of Patients With Anemia Associated With Chronic Kidney Disease September 2006 February 2008
NCT00442702 Completed Phase 3 A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis. September 2007 August 2010
NCT00442793 Completed Phase 3 A Study Comparing Mircera and Epoetin Beta for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease. May 2007 May 2010
NCT00446576 Completed Phase 3 The Effect of Epoetin Alfa on Cardiac Function and Quality of Life in Patients With Early Renal ((Kidney) Disease November 1999 April 2003
NCT00466063 Completed ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox May 2007 July 2015
NCT00470158 Completed Phase 4 Delivery of Iron and Zinc Supplements: Evaluation of Interaction Effect on Biochemical and Clinical Outcomes May 2007 February 2008
NCT00478582 Completed N/A Validation of a New Standardized Clinical Anemia Evaluation Score Using a Hb Visual Scale in Nephrological Patients May 2007 December 2007
NCT00508131 Completed Phase 3 Effectiveness of Iron-Fortified Milk on Iron Status and Anemia in Young Children in Mexico May 2003 July 2004
NCT00508417 Completed Malaria Incidence in Infants in Bancoumana, Mali July 24, 2007 February 11, 2011
NCT00517413 Completed Phase 3 LATINO Study: A Study of Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia. October 2007 May 2010
NCT00524407 Completed Phase 4 Effect of Epoetin Alfa on Hemoglobin, Symptom Distress, and Quality of Life in Patients Receiving Chemotherapy July 1996 November 2002
NCT00526747 Completed Erythropoietin Resistance in Anemia of Chronic Kidney Disease August 2007 June 2008
NCT00540384 Completed Phase 1/Phase 2 Dose-finding Study of Novel Erythropoiesis Stimulating Protein (NESP) for the Treatment of Anaemia in Subjects With Solid Tumours Receiving Multicycle Chemotherapy July 1999 June 2002
NCT00540696 Completed Phase 2 Study to Develop a Screening Tool for Functional Capacity in Anemic Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Darbepoetin Alfa September 2001 September 2003
NCT00542568 Completed Phase 1/Phase 2 Safety and Efficacy of Sustained Erythropoietin Therapy August 2008 January 2013
NCT00545571 Completed Phase 3 MIRACLE Study: A Study of Once-Monthly Intravenous Mircera in Hemodialysis Participants With Chronic Renal Anemia October 2007 October 2009
NCT00546481 Completed Phase 3 A Study of Intravenous Mircera for the Correction of Anemia in Dialysis Patients. November 2007 December 2009
NCT00548691 Completed Phase 3 Safety and Tolerability of FCM vs Standard of Care in Treating Iron Deficiency Anemia in Chronic Kidney Disease Patients October 2007 July 2009
NCT00548860 Completed Phase 3 Safety of FCM vs. Standard of Care in Treating Iron Deficiency Anemia in Heavy Uterine Bleeding and Post Partum Patients October 2007 July 2009
NCT00558454 Completed Phase 4 Iron Supplementation of Marginally Low Birth Weight Infants March 2004 November 2014
NCT00559195 Completed Phase 2 Epoetin Beta in Treating Fatigue and Anemia in Patients Receiving Palliative Care for Malignant Solid Tumors November 2005
NCT00559637 Completed Phase 3 A Study of Subcutaneous Mircera in Participants With Chronic Kidney Disease Not Treated With ESA or on Dialysis January 2008 June 2010
NCT00560274 Completed Phase 4 A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C. March 2008 November 2011
NCT00560404 Completed Phase 3 A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia. April 2008 December 2010
NCT00563446 Completed N/A Study of the Efficacy of Darbepoetin Alfa in the Treatment of Renal Anemia July 2005 May 2006
NCT00576303 Completed Phase 3 A Study of Intravenous Mircera in Dialysis Patients With Chronic Renal Disease and Anemia. April 2008 June 2010
NCT00576628 Completed Phase 3 A Study of Subcutaneous C.E.R.A. for the Treatment of Anemia in Pre-Dialysis Patients. May 2008 March 2010
NCT00593801 Completed N/A Erythropoietin Treatment in Extremely Low Birth Weight Infants May 1998 June 1999
NCT00597584 Completed Phase 3 Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis October 2007 January 2010
NCT00597753 Completed Phase 3 Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis September 2007 January 2010
NCT00598273 Completed Phase 3 Safety & Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis October 2007 February 2010
NCT00598442 Completed Phase 3 Safety and Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis November 2007 December 2009
NCT00605293 Completed Phase 3 A Study of Intravenous Mircera (C.E.R.A or Methoxy Polyethylene Glycol-epoetin Beta) for the Maintenance Treatment of Hemodialysis Participants With Chronic Renal Anemia January 2008 January 2010
NCT00605345 Completed Phase 3 A Study Comparing Subcutaneous Mircera and Darbepoetin Alfa for Maintenance Treatment of Anemia in Kidney Transplant Recipients. December 2007 July 2009
NCT00628043 Completed Phase 3 Clinical Study of Epoetin Beta to Chemotherapy-Induced Anemia (CIA) Patients May 2008 September 2009
NCT00628459 Completed N/A Effect of Iron Versus Multiple Micronutrient Supplementation on Anemia in Preschool Children of Malaria-Endemic Area August 2006 February 2008
NCT00629629 Completed N/A Impacts of the 10 Steps for Healthy Feeding in Infants: a Randomized Field Trial October 2001 May 2015
NCT00640172 Completed Anemia in the Elderly August 2009 December 2011
NCT00641589 Completed Phase 1 A Study to Determine the Pharmacokinetic and Pharmacodynamic Profiles of PROCRIT (Epoetin Alfa) in Anemic Patients With Chronic Kidney Disease January 2006 November 2006
NCT00642304 Completed Phase 3 A Study of Subcutaneous C.E.R.A. for the Maintenance of Hemoglobin Levels in Participants With Chronic Renal Anemia Not on Dialysis. March 27, 2008 December 9, 2009
NCT00642668 Completed Phase 4 A Study of Subcutaneous Mircera for the Maintenance Treatment of Participants With Chronic Renal Anemia June 30, 2008 December 31, 2009
NCT00642850 Completed Phase 3 STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients November 2007 July 2009
NCT00642967 Completed Phase 3 A Study of Subcutaneous Mircera for the Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease Not on Dialysis June 2008 August 2010
NCT00651573 Completed N/A Balancing Risk: Red Blood Cell Transfusion Strategies In Cardiac Surgery March 2007 January 3, 2019
NCT00655408 Completed N/A Iron-Deficiency Anemia in Infants in Two Weekly Programs April 2003 January 2004
NCT00659061 Completed N/A Monitoring and Evaluation of Micronutrients (Sprinkles) Project August 2007 May 2008
NCT00660023 Completed Phase 3 A Study of Intravenous Mircera in Participants With Chronic Renal Anemia Who Are on Dialysis August 2008 November 2010
NCT00660933 Completed Phase 4 Intravenous Iron Versus Oral Iron for Severe Postpartum Anemia September 2005 September 2007
NCT00661388 Completed Phase 3 A Study of Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Predialysis Patients Not Treated With ESA. August 2008 December 2010
NCT00661505 Completed Phase 3 A Study of Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia May 14, 2008 June 22, 2010
NCT00661999 Completed Phase 3 Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer January 2006 March 2009
NCT00666835 Completed Phase 3 Study to Evaluate the Efficacy and Safety of HX575 Hexal AG vs ERYPO® for the Treatment of Anemia in Hemodialysis Patients April 2004 January 2006
NCT00680043 Completed Phase 2 Safety & Efficacy of Peginesatide for Treatment of Anemia in Participants on Dialysis Not Receiving an ESA June 2008 August 2009
NCT00687258 Completed Phase 2 Evaluation Of A New Vitamin E-Bonded Membrane On Anemia And Oxidative Stress In End-Stage Renal Disease Patients July 2006 July 2007
NCT00699348 Completed Phase 3 A Study of Monthly Intravenous C.E.R.A. (Mircera) in Hemodialysis Participants With Chronic Renal Anemia July 2008 July 2010
NCT00701246 Completed N/A Treatment and Prevention of Anemia With Ferrous Sulfate Plus Folic Acid in Children in Goiania - Goias, Brazil April 2005 March 2006
NCT00703937 Completed Phase 3 Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Standard of Care in Treating Iron Deficiency Anemia July 2008 March 2011
NCT00704028 Completed Phase 3 Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Iron Dextran in Treating Iron Deficiency Anemia June 2008 March 2011
NCT00704353 Completed Phase 3 Safety and Tolerability of a Single Dose of FCM vs. Standard of Care in Treating Iron Deficiency Anemia June 2008 March 2011
NCT00711958 Completed Phase 3 Study to Assess the Efficacy and Safety of HX575 in the Treatment of Chemotherapy Associated Anemia in Cancer Patients November 2004 December 2005
NCT00717821 Completed Phase 3 A Study of Once Monthly Intravenous or Subcutaneous Mircera in Participants With Chronic Kidney Disease on Hemodialysis. August 2008 July 2011
NCT00721188 Completed Phase 2 Iron Sucrose in Non-Dialysis Dependent (NDD-CKD) Pediatric Patients January 2006 January 2010
NCT00727571 Completed LEARN-6™: A Prospective, Observational Nursing Home Study September 2006 July 2008
NCT00730314 Completed Phase 1/Phase 2 Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells August 2008 August 2015
NCT00735930 Completed Phase 1 Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma August 2008 November 2014
NCT00737464 Completed Phase 4 A Study of Once Monthly Intravenous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia. August 26, 2008 September 12, 2009
NCT00737477 Completed Phase 3 A Study of Monthly Subcutaneous (SC) Mircera for Maintenance Treatment of Participants With Chronic Kidney Disease on Peritoneal Dialysis September 30, 2008 July 31, 2011
NCT00737711 Completed Phase 4 A Study of Two-Weekly Intravenous Mircera for the Treatment of Dialysis Patients With Chronic Renal Anemia Not Receiving ESA Therapy. July 2008 October 2009
NCT00740246 Completed Phase 3 Safety and Tolerability of Intravenous VIT-45 in Patients With Iron Deficiency Anemia June 2005
NCT00744445 Completed Phase 2 Erythropoietin Therapy in Patients With Chronic Renal Failure: A Study of Time Dependent Activity October 1993 August 1998
NCT00746551 Completed Phase 4 Intravenous Versus Oral Iron in Late Pregnancy: Results of Treatment September 2008 April 2010
NCT00752609 Completed Phase 2 Safety and Efficacy of Peginesatide Injection for the Maintenance of Anemia in Chronic Renal Failure Participants Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa. September 2008 December 2009
NCT00752791 Completed Phase 2 Efficacy and Safety of Peginesatide Injection for the Maintenance Treatment of Anemia in Peritoneal Dialysis Participants Previously Treated With Epoetin. October 2008 May 2010
NCT00761657 Completed Phase 2 Phase 2 Study of Roxadustat in Participants With Anemia and Chronic Kidney Disease Not Requiring Dialysis November 1, 2006 June 21, 2010
NCT00771810 Completed Phase 2 Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer October 2008 December 2011
NCT00772083 Completed N/A Caring for Those Who Share: Improving the Health of Wisconsin Blood Donors November 2008 June 2009
NCT00773331 Completed Phase 3 A Study Comparing Maintenance of Hemoglobin Levels, Safety and Tolerability of Once Every 4 Weeks Mircera Versus Epoetin Beta in Dialysis Patients With Chronic Renal Anemia. July 2009 December 2010
NCT00773968 Completed Phase 3 A Study of Monthly Subcutaneous Continuous Erythropoietin Receptor Activator (CERA) in Predialysis Participants With Chronic Renal Anemia September 2008 March 2010
NCT00776425 Completed Phase 4 A Study of the Quality of Life and Treatment Response to Once Weekly Epoetin Beta (Recormon) Treatment in Anemic Participants With Solid and Lymphoid Malignancies January 2007 November 2012
NCT00787124 Completed Transfusions and Nitric Oxide Level in Preterm Infants September 2008 September 2009
NCT00810030 Completed Phase 3 FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR October 2008 April 2010
NCT00822380 Completed N/A Evaluation of the Efficacy of Different Strategies to Treat Anemia in Mexican Children March 2003 November 2004
NCT00827463 Completed Phase 3 Early Detection of Anaemia During the Maternity January 2009 December 2009
NCT00834691 Completed An Evaluation of the Causes of Anemia in Patients With Heart Failure January 2008
NCT00839761 Completed N/A The Use of Ultra Rice Compared to Iron Drops Consumed by Anemic Children December 2006 March 2008
NCT00882713 Completed Phase 3 A Study of Once Monthly Subcutaneous Mircera in Dialysis Patients With Chronic Renal Anemia February 2009 October 2010
NCT00883415 Completed Myocardial Glucose Uptake (MGU) in Patients With Chronic Kidney Disease May 2008 November 2012
NCT00899665 Completed Proteases in Patients With Prostate Cancer That Has Spread to the Bone July 2001 January 2008
NCT00906295 Completed N/A Establishment of Optimal Transfusion Threshold After Major Orthopedic Surgery June 2009 June 2011
NCT00920413 Completed Phase 3 Oral Vitamin C for Correction of Anemia in Patients Receiving Peritoneal Dialysis March 2002
NCT00922116 Completed Phase 4 A Study of Once Monthly Subcutaneous Mircera in Patients With Chronic Renal Anemia Not on Dialysis April 30, 2009 November 30, 2010
NCT00922610 Completed Phase 4 A Study of Mircera in Renal Anemia Among Filipino Chronic Kidney Disease Patients February 2009 July 2010
NCT00925587 Completed Phase 3 Evaluation of Monthly Darbepoetin Alfa Dosing for Correction of Anemia in Non-dialysis Chronic Kidney Disease June 2009 May 2012
NCT00936091 Completed N/A Effects of Vitamin A Supplementation on Intestinal Parasitic Reinfections May 2007 August 2008
NCT00944112 Completed N/A Restrictive and Liberal Transfusion Strategies in Intensive Care August 2009 November 2010
NCT00953134 Completed Early Phase 1 Periconceptional Iron Supplementation in Rural Bangladesh February 2007 March 2008
NCT00967109 Completed N/A Establishment of Optimal Transfusion Threshold During Spine Surgery September 2009 February 2011
NCT00970840 Completed N/A Acceptability of Lipid-Based Nutrient Supplements (LNS) for Women and Infants June 2009 June 2009
NCT00970866 Completed N/A Efficacy of Lipid-Based Nutrient Supplements (LNS) for Pregnant and Lactating Women and Their Infants November 2009 December 15, 2017
NCT00978575 Completed Phase 4 Iron Substitution After Upper Gastro-Intestinal Bleeding April 2010 April 2013
NCT00992823 Completed N/A Iron Supplementation to Reduce Preschoolers Anemia: Comparison Between Intermittent and Cyclic Procedure March 2006 July 2008
NCT01001871 Completed N/A Treatment of Iron Deficiency Anemia in Malaria Endemic Ghana November 2009 May 2011
NCT01011361 Completed Red Cell Mass and Plasma Volume Measurements in Elderly Men and Women With Anemia April 2009 June 2011
NCT01012063 Completed N/A Perioperative Iron With Erythropoietin in Bilateral Total Knee Replacement Arthroplasty (TKRA) August 2008 October 2009
NCT01018043 Completed Thai Cancer Anemia Survey in Chulalongkorn Hospital April 2006 December 2009
NCT01019902 Completed Impact of Maternal Iron Status on Neonatal Iron Status and Auditory Brainstem Response in the Newborn October 2008 October 2013
NCT01029262 Completed Phase 3 A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Lower Risk Myelodysplastic Syndrome (MDS) Without Del 5q January 26, 2010 May 9, 2018
NCT01030159 Completed National Cancer Institute Thai Cancer Anemia Survey June 2006 May 2008
NCT01032005 Completed N/A Efficacy of Double Fortified Salt (DFS) to Improve Work Productivity in Women in India May 2009 September 2010
NCT01033175 Completed N/A The Impact of Anemia of Chronic Disease on Chronic Obstructive Pulmonary Disease Patients December 2009 June 2010
NCT01038557 Completed N/A Frozen Red Blood Cell Transfusions in Trauma Patients January 2010 May 2014
NCT01051323 Completed An Observational Study of Mircera (Methoxy Polyethylene Glycol-epoetin Beta) in Patients With Renal Anemia March 2010 February 2013
NCT01052779 Completed Phase 2 A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney Disease March 1, 2010 April 19, 2012
NCT01055431 Completed Phase 1 A Functional Food for the Prevention of Iron-deficiency Anemia October 2009 July 2011
NCT01081977 Completed Phase 2 Effect of Timing of Umbilical Cord Clamping on Haematological and Clinical Outcomes of Infants August 2008 April 2010
NCT01083888 Completed Phase 1 ASP1517 Pharmacokinetics Study in Anemia Patients on Hemodialysis February 15, 2010 June 7, 2010
NCT01086878 Completed Phase 4 Safety of Cotrimoxazole in HIV- and HAART-exposed Infants February 2009 October 2010
NCT01090843 Completed N/A Video Capsule Endoscopy (VCE) Comparison Study April 2010 October 2011
NCT01092377 Completed N/A The Effects of Iron and Omega-3 Fatty Acid Supplementation on Cognition and Immune Function in Iron Deficient Children February 2010 December 2010
NCT01093989 Completed N/A Acute vs. Delayed Iron Therapy: Effect on Iron Status, Anemia and Cognition June 2010 December 2014
NCT01105494 Completed An Observational Study of Epoetin Beta [Neorecormon] to Evaluate the Quality of Life in Patients on Dialysis With Chronic Renal Anemia December 2008 June 2012
NCT01115478 Completed N/A Malaria in Pregnancy: Nutrition and Immunologic Effects July 2010 June 2014
NCT01119612 Completed N/A Prenatal Iron Supplements: Safety and Efficacy in Tanzania September 2010 May 2013
NCT01135849 Completed B-Receptor Signaling in Cardiomyopathy November 2008 October 2010
NCT01146574 Completed Phase 2 A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis. June 30, 2010 March 7, 2016
NCT01147666 Completed Phase 2 Study of Roxadustat (FG-4592) in Participants With End-Stage Renal Disease Receiving Maintenance Hemodialysis May 17, 2010 October 15, 2012
NCT01156363 Completed Phase 4 A Study of Monthly Subcutaneous or Intravenous Mircera in Dialysis Patients With Chronic Renal Anaemia October 2010 January 2013
NCT01183572 Completed N/A Trial of Pre-Pregnancy Supplements August 2010 January 2012
NCT01191463 Completed N/A The Efficacy of a Local Vitamin-C Rich Fruit (Guava) in Improving Iron Absorption From Mungbean Based Meals and Its Effect on Iron Status of Rural Indian Children (6-10 Years) September 2010 April 2011
NCT01191983 Completed Phase 4 A Study of Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) for the Treatment of Chronic Renal Anemia in Participants With Diabetic Nephropathy August 13, 2010 April 23, 2018
NCT01196533 Completed N/A A Comparative Clinical Trial of the TensorTip, a Novel Non Invasive Device for Measurement Blood Parameters August 2010 August 2014
NCT01198574 Completed Phase 3 Sub-clinical Inflammation and Iron Supplementation July 2010 December 2010
NCT01208363 Completed N/A Improving Iron Status Through Consumption Of Iron Fortified Cowpea: An Intervention Study September 2010 July 2011
NCT01213485 Completed An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Patients With Chronic Kidney Disease on Dialysis (HORTENSIA) March 2010 October 2011
NCT01224236 Completed Phase 2/Phase 3 Randomized Trial of Iron Supplementation to Prevent Anemia in Very-low-birth-weight Infants July 2010 February 2012
NCT01224535 Completed N/A Improving Iron Status of Children: Potential of Amaranth October 2010 June 2011
NCT01229761 Completed Phase 2 Study to Improve Survival Among HIV-Exposed Infants in Botswana May 2011 October 2018
NCT01235936 Completed Phase 2 Safety and Efficacy Study for AKB-6548 in Participants With Chronic Kidney Disease and Anemia October 21, 2010 May 2011
NCT03897673 Enrolling by invitation N/A Optimizing Benefits While Reducing Risks of Iron in Malaria-endemic Areas September 1, 2019 July 1, 2024
NCT05312658 Enrolling by invitation N/A Aortic Compression Trial to Reduce Blood Loss at Cesarean Section December 1, 2022 December 2026
NCT05603793 Enrolling by invitation YoUng Adolescents' behaViour, musculoskeletAl heAlth, Growth & Nutrition September 13, 2022 September 25, 2050
NCT01892202 No longer available A Non-Interventional Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Patients With Chronic Kidney Disease Not on Dialysis February 2011 February 2011
NCT06234332 Not yet recruiting Peking University Birth Cohort in Weifang (PKUBC-WF) February 1, 2024 December 31, 2043
NCT04168346 Not yet recruiting Phase 4 Preoperative Intravenous Iron Therapy in Patients With Gastric Cancer November 2019 November 2026
NCT04544540 Not yet recruiting N/A One Versus Two Unit Transfusions in Oncology Patients - The OTTOP Trial: A Randomized Open-label Pragmatic Controlled Trial November 1, 2020 December 1, 2024
NCT05258825 Not yet recruiting Phase 4 Preoperative Monoferric for Abdominal Surgery November 1, 2022 April 2023
NCT05735314 Not yet recruiting N/A A New Combination of Evidence-Based Interventions to Improve Primary Care Diagnostic Safety and Efficiency May 15, 2023 March 31, 2025
NCT05407987 Not yet recruiting Phase 3 Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery) September 1, 2024 December 30, 2025
NCT05691257 Not yet recruiting Phase 4 Study of the Safety and Efficacy of Roxadustat in the Treatment of Heart Failure With Chronic Kidney Disease and Anemia February 1, 2023 December 1, 2023
NCT06309641 Not yet recruiting Methemoglobinemia Following Intravenous Iron Treatment September 2024 December 2025
NCT06438458 Not yet recruiting N/A Effect of Postural Change on Hemoglobin Level in Patients on the Intensive Care Unit June 17, 2024 October 30, 2024
NCT05648942 Not yet recruiting N/A Can Pre-operative Anemia be Timely Identified and Optimized in Patients Awaiting Primary Arthroplasty Surgery? A Randomized Clinical Trial January 1, 2023 January 1, 2025
NCT06245746 Not yet recruiting Phase 1 UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia March 2024 December 2025
NCT06198790 Not yet recruiting Postoperative Anemia After Bariatric Surgery February 1, 2024 December 31, 2027
NCT03700034 Not yet recruiting N/A mHealth Integrated Model of Hypertension, Diabetes and Antenatal Care in India and Nepal December 2023 March 2024
NCT05672420 Not yet recruiting Phase 1/Phase 2 Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignancies January 1, 2023 January 31, 2025
NCT05704894 Not yet recruiting Phase 3 Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in Childrens May 2023 November 2025
NCT05060731 Not yet recruiting Phase 4 Iron Supplementation in Upper Non-variceal Gastrointestinal Bleeding September 1, 2024 February 1, 2027
NCT05929729 Not yet recruiting Phase 4 Iron Deficiency Anemia (IDA) December 1, 2023 September 1, 2028
NCT05913414 Recruiting Phase 2 Iron Isomaltide for Iron-deficiency Anemia Patients With Locally Advanced Nasopharyngeal Carcinoma May 5, 2023 May 30, 2026
NCT05732961 Recruiting Phase 2 Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms February 21, 2023 May 2025
NCT06250595 Recruiting European Rare Blood Disorders Platform (ENROL) July 1, 2022 July 2037
NCT03945968 Recruiting The Role of Concomitant Diseases in Postoperative Complications Risk Stratification. July 1, 2019 February 28, 2025
NCT03369210 Recruiting Phase 3 Liberal Transfusion Strategy in Elderly Patients December 4, 2017 December 31, 2025
NCT05924100 Recruiting Phase 2 Efficacy and Safety of Luspatercept for the Treatment of Anemia Due to MDS With del5q, Refractory/Resistant/Intolerant to Prior Treatments, RBC-TD November 3, 2022 November 3, 2028
NCT05768997 Recruiting Phase 3 High Dose IV Iron Plus ESA in Chemotherapy-induced Anemia March 1, 2023 December 31, 2025
NCT04935866 Recruiting Optimal Brain Oxygenation in Neurologic Intensive Care Unit : The NeurO2 Study May 7, 2021 July 2025
NCT05448456 Recruiting Phase 4 Use of Tranexamic Acid After Vaginal Delivery With Episiotomy a RCT Placebo Control Trail July 25, 2022 July 10, 2024
NCT04920045 Recruiting N/A A Trial to Assess the Effect of Transfusion Strategies on Fatigability Levels After Hospital Discharge February 1, 2022 July 2026
NCT05447442 Recruiting Guideline Adherence for Preoperative Anemia Management in a PAC October 1, 2022 June 2025
NCT05773586 Recruiting Phase 1 A Study to Investigate the Safety, Pharmacokinetics and Efficacy of APG-5918 in Healthy Subjects or Anemic Patients March 13, 2023 March 15, 2026
NCT06218953 Recruiting The Impact of Preoperative Anemia on Postoperative Anemia and Related Nutrient Abnormalities After Bariatric Surgery September 1, 2017 December 31, 2024
NCT05664737 Recruiting Phase 2 A Study to Determine the Efficacy and Safety of Luspatercept in Adult and Adolescent Participants With Alpha (α)-Thalassemia December 9, 2022 June 18, 2026
NCT04455841 Recruiting Phase 1/Phase 2 INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders March 19, 2021 June 30, 2026
NCT03850964 Recruiting Phase 2/Phase 3 Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz) May 8, 2023 March 31, 2026
NCT05699005 Recruiting Phase 1 Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO September 18, 2023 December 18, 2025
NCT02876211 Recruiting Phase 4 Paricalcitol Improves Anemia of Inflammation December 2014 December 2024
NCT03037164 Recruiting Phase 3 INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections May 11, 2017 January 30, 2026
NCT05800600 Recruiting Phase 2 Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy March 15, 2023 February 1, 2026
NCT05384691 Recruiting Phase 2 Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions September 27, 2022 July 31, 2027
NCT05382065 Recruiting Anemia and Duration of Mechanical Ventilation July 8, 2022 December 2023
NCT06170749 Recruiting Prediction Model for Anemia After Bariatric Surgery September 1, 2017 December 31, 2025
NCT06159348 Recruiting Pilot Feasibility Study of a Novel Non-invasive Device for Diagnosis of Anemia November 30, 2023 December 2024
NCT05320198 Recruiting Phase 1/Phase 2 Study of DISC-0974 in Participants With Myelofibrosis and Anemia June 6, 2022 October 2024
NCT05820464 Recruiting Diastolic Deceleration Area in Early-onset FGR April 19, 2022 April 1, 2024
NCT05837195 Recruiting Diastolic Deceleration Area in Late-onset FGR April 19, 2023 June 30, 2024
NCT06124586 Recruiting N/A Early Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS) February 1, 2024 November 1, 2028
NCT04155489 Recruiting N/A The Impact of Perioperative Transfusion on Postoperative Cognitive Dysfunction January 8, 2020 October 31, 2024
NCT04707261 Recruiting Phase 4 Association Between Dapagliflozin-induced Improvement and Anemia in Heart Failure Patients (ADIDAS) August 6, 2021 January 1, 2025
NCT05242055 Recruiting Integrated Diagnosis and Treatment of CKD on Outcomes February 1, 2022 December 31, 2026
NCT04717414 Recruiting Phase 3 An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions February 25, 2021 August 23, 2025
NCT05856357 Recruiting Perennial Malaria Chemoprevention (PMC) in Côte d'Ivoire August 11, 2023 July 2025
NCT05634005 Recruiting N/A Clinical Decision Support for Blood Transfusions to Improve Guideline Adherence February 1, 2023 December 2024
NCT04083755 Recruiting Phase 4 Impact of Intravenous Iron Treatment of Preoperative Anemia in Patients With LEAD (IRONPAD) August 15, 2019 December 31, 2025
NCT05233956 Recruiting N/A Levonorgestrel Intrauterine System Effects on Hemoglobin and Serum Ferritin Among Anemic Women in Kenya October 23, 2023 February 2026
NCT05693194 Recruiting Pathophysiology of Anemia in PICU Survivors October 3, 2019 September 2023
NCT06080893 Recruiting The Effect of Preoperative Ferric Carboxymaltose Administration on Mortality in Geriatric Hip Fractures October 10, 2023 January 2025
NCT05750654 Recruiting N/A Effectiveness of Small Phlebotomy Tubes in Reducing Blood Transfusions in Adult Medical Intensive Care Unit and Intermediate Care Unit Patients With Anemia July 24, 2023 July 31, 2025
NCT03683810 Recruiting Phase 1 The Effectiveness of Lactoferrin in the Management of Treatment-induced Anemia January 14, 2019 June 2023
NCT05211037 Recruiting N/A Screening for Renal Complications in Children and Young Adults With Major Sickle Cell Disease September 15, 2022 September 2024
NCT05881447 Recruiting Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa June 21, 2023 December 31, 2025
NCT05889052 Recruiting Perennial Malaria Chemoprevention (PMC) in Cameroon July 19, 2023 July 2025
NCT06066151 Recruiting N/A The Efficacy of Minayo Iron-rich Yeast Drink With SOD on Female Nutritional Anemia, Skin Condition and Qi-blood Deficiency Syndrome September 10, 2023 December 15, 2023
NCT00106015 Recruiting Diamond Blackfan Anemia Registry (DBAR) September 2004 April 2026
NCT05752955 Recruiting N/A SMART Health Pregnancy 2 - Intervention to Reduce Anaemia and Cardiometabolic Risk During Pregnancy and in the First Year Following Birth June 6, 2022 December 2024
NCT05505006 Recruiting Phase 4 Management of Preoperative Anaemia in Surgical Oncology March 2, 2021 August 13, 2024
NCT05496309 Recruiting Causes and Mechanisms of Space Hemolysis at High Altitudes June 1, 2024 November 30, 2024
NCT05146726 Recruiting Patient Blood Management Charité (PBM-Charité): Structured Detection, Differentiated Diagnostics and Therapy of Preoperative Anemia and Use of Machine Autotransfusion in Elective Interventions February 2, 2022 February 2027
NCT05126901 Recruiting Phase 3 Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years October 4, 2021 July 2024
NCT05490823 Recruiting N/A Validation of a Smartphone App for Anemia Screening Among General Population December 1, 2018 December 1, 2022
NCT03217656 Recruiting The Jiaxing Birth Cohort in China January 1999 January 2029
NCT06060639 Recruiting N/A Variation of Echocardiographic Parameters After Red Blood Cell Transfusion in Emergency Department Anemic Patients November 9, 2023 November 9, 2024
NCT05891249 Recruiting Phase 4 A Study to Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (TD) Anemia Associated With Myelodysplastic Syndromes (MDS) & Beta-thalassemia (β-Thal) in India June 5, 2023 April 13, 2026
NCT06318858 Recruiting N/A Daily and Weekly Iron Supplementation in Infants March 15, 2023 October 14, 2024
NCT06042699 Recruiting N/A Scoliosis Iron Supplementation Study January 11, 2024 January 30, 2028
NCT06038630 Recruiting Phase 2 129Xe MRI Cardiopulmonary January 12, 2024 June 30, 2028
NCT06025786 Recruiting N/A Impact Evaluation of Benazir Nashonuma Program (BNP) on Stunting Among Under-five Children December 1, 2021 June 30, 2026
NCT06012760 Recruiting N/A The Effect of Combined Iron Protocols on Perioperative Allogeneic Transfusion April 1, 2024 March 31, 2026
NCT00921635 Suspended Phase 3 A Study to Evaluate the Impact of Maintaining Hemoglobin Levels in Anemic Patients With Carcinoma of the Cervix April 2008
NCT01328262 Terminated N/A A Randomized Clinical Trial on Hemoglobin Dose and Patient Matching November 2010 March 2019
NCT01345968 Terminated Phase 4 Intravenous Ferric Carboxymaltose (Ferinject) in Patients Undergoing Orthopaedic Surgery June 2011 February 2013
NCT00240734 Terminated Phase 2 Treatment of Anemia in Diabetic Subjects With CKD March 2005 September 2005
NCT00246298 Terminated Phase 2 A Study to Assess the Effectiveness of PROCRIT (Epoetin Alfa) Dosing Every 2 Weeks Versus Once a Week in Anemic HIV-infected Patients October 2005 September 2006
NCT00246597 Terminated Phase 3 A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer December 2002 June 2004
NCT00083434 Terminated Phase 3 Treatment of Anemic Patients With Cancer Who Are Not Receiving Chemotherapy or Radiotherapy February 2004 October 2004
NCT00210795 Terminated Phase 2 A Phase II Study to Assess Changes in Physical Function in Elderly Patients With Chronic Anemia June 2004 October 2005
NCT00258440 Terminated N/A Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer May 2003 September 2008
NCT02943668 Terminated Phase 2 Deferasirox in Treating Patients With Very Low, Low, or Intermediate-Risk Red Blood Cell Transfusion Dependent Anemia or Myelodysplastic Syndrome March 2, 2017 December 17, 2018
NCT02972294 Terminated Phase 3 HiFIT Study : Hip Fracture: Iron and Tranexamic Acid March 31, 2017 September 16, 2021
NCT01504945 Terminated Phase 1/Phase 2 Red Blood Cell Transfusion in Patients With Coronary Artery Disease (CAD) February 2010 December 2017
NCT01506726 Terminated Phase 2 Trial To Evaluate the Efficacy of Oral Salsalate in the Treatment of Older Adults With Unexplained Anemia March 2012 November 2014
NCT01535781 Terminated N/A Study of the Effect of Tranexamic Acid Administered to Patients With Hip Fractures. Can Blood Loss be Reduced? September 2011 August 2014
NCT01546337 Terminated Search for Predictive Markers of Efficacy of ESAs in Patients With Non-myeloid Malignancies or Myelodysplastic Syndrome May 2008 November 2009
NCT01555515 Terminated Phase 1/Phase 2 Epodure Therapy of Anemia in End Stage Renal Disease on Dialysis With Epodure Skin Implant March 2012 April 2014
NCT03017742 Terminated Utility of Non-invasive Carboxyhemoglobin and Total Hemoglobin Measurement in the Emergency Department November 2016 December 11, 2017
NCT00228995 Terminated Phase 2 A Phase II Study to Assess Changes in Physical Function in Elderly Patients With Chronic Anemia June 2004 September 2005
NCT00302939 Terminated Etiology of Anemia January 2006 December 2010
NCT00306267 Terminated Phase 2 A Study of PROCRIT (Epoetin Alfa) 80,000 Units (U) Once Every Four Weeks (Q4W) vs. 40,000 U Once Every Two Weeks (Q2W) in Cancer Patients Not Receiving Chemotherapy March 2006 May 2007
NCT00310232 Terminated Phase 3 Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20) February 2001 April 2004
NCT00312871 Terminated Phase 4 Effects of Early Correction of Anemia in Patients With Chronic Renal Insufficiency February 2001 June 2003
NCT00210730 Terminated Phase 3 The Duration Study June 2004 July 2005
NCT03092297 Terminated Insufficient Cellular Oxygen in ICU Patients With Anaemia May 16, 2017 December 1, 2022
NCT00338468 Terminated Phase 4 A Study to Assess Disability in Anemic Elderly Patients With Kidney Disease Receiving PROCRIT (Epoetin Alfa) November 2003 September 2005
NCT01695759 Terminated Phase 3 Clinical Efficacy of Two Erythropoietin Drug in Participants With Secondary Anemia to Chronic Kidney Disease. December 2013 January 2018
NCT00350090 Terminated Phase 3 A Study to Assess the Response Rate of PROCRIT (Epoetin Alfa) Given at a Dose of 40,000 Units Once a Week to Cancer Patients With Anemia Who Are Not Receiving Chemotherapy. September 2002 March 2004
NCT00223938 Terminated Phase 4 Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients. December 30, 2003 April 27, 2007
NCT03140722 Terminated Phase 2 Study to Evaluate Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Who Are Hyporesponsive to Erythropoiesis Stimulating Agents May 2, 2017 March 21, 2018
NCT00364845 Terminated Phase 3 STIMULATE Study: Anemia Correction and Health-related Quality of Life (HRQoL) Outcomes in Elderly Chronic Kidney Disease (CKD) Patients September 2006 February 2009
NCT00372489 Terminated Phase 2 Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD September 2006 November 2009
NCT01737879 Terminated Phase 4 Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Patients Receiving Hemodialysis October 2012 July 2013
NCT00381836 Terminated Phase 2/Phase 3 Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate Cancer October 2006 February 2007
NCT03214627 Terminated N/A Artificial Intelligence for Optimal Anemia Management in End-stage Renal Disease: The Anemia Control Model (ACM) Trial December 10, 2018 May 21, 2019
NCT00386152 Terminated Phase 2 A Study Comparing Two Different PROCRIT Doses to a Dose of ARANESP in Anemic Cancer Patients Receiving Chemotherapy November 2006 May 2008
NCT03277183 Terminated Phase 4 Frequent, Low-Dose Erythropoietin A Mechanistic Approach to Mitigate Adverse Cardiovascular Effects of Erythropoietin November 2, 2017 June 3, 2019
NCT01817699 Terminated Phase 4 Correcting Anemia and Native Vitamin D Supplementation in Kidney Transplant Recipients April 2013 December 2018
NCT03303950 Terminated Phase 2 Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis March 30, 2018 February 19, 2020
NCT00422513 Terminated Phase 3 A Study Comparing Mircera and Epoetin Alfa for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease. March 2007 December 2007
NCT00436748 Terminated Phase 3 Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney Disease September 16, 2008 March 3, 2014
NCT01837082 Terminated Phase 3 Iron in Congestive Heart Failure April 2013 December 2015
NCT00440063 Terminated Phase 4 A Study of NeoRecormon (Epoetin Beta) in Patients With Renal Anemia.
NCT00442416 Terminated Phase 3 A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients. February 2007 January 2008
NCT00450333 Terminated Phase 3 Dynepo Infrequent Dosing Study October 30, 2006 July 31, 2008
NCT00453973 Terminated Phase 2 Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD (EU) November 2006 September 2009
NCT00454246 Terminated Phase 3 A Study of Mircera in Hemoglobin Control of Patients Transitioning to Dialysis. April 2007 February 2008
NCT00462384 Terminated Phase 3 A Study of Subcutaneous Mircera for the Treatment of Anemia in Pre-Dialysis Participants With Chronic Kidney Disease. February 2008 April 2011
NCT00495365 Terminated Phase 4 A Dose Conversion Study of Epoetin Alfa in Subjects With the Anemia of Chronic Kidney Disease. June 2003 September 2003
NCT00495378 Terminated Phase 4 RAPID-2. A Study to Evaluate the Effectiveness of Alternate Dosing of PROCRIT (Epoetin Alfa) in Maintaining Hemoglobin Levels in Patients With Chemotherapy Related Anemia November 2002 March 2003
NCT00497471 Terminated N/A RCT Iron Supplementation and Malaria Chemoprophylaxis for Prevention of Severe Anemia and Malaria in Tanzanian Infants February 1995 July 1999
NCT00511901 Terminated Phase 4 Prevalence and Treatment of Anemia in Rehabilitation Patients November 2005 May 2008
NCT00514813 Terminated Phase 4 Dynepo Long-Term Safety Study June 6, 2007 July 31, 2008
NCT00517881 Terminated Phase 3 Efficacy, Safety and Tolerability Study of Subcutaneous C.E.R.A. in Pre-Dialysis Participants With Chronic Renal Anemia June 2007 November 2009
NCT00534456 Terminated Phase 3 An Exploratory Sub-study for the RED-HF™ (Reduction of Events With Darbepoetin Alfa in Heart Failure) Trial January 2007 October 2007
NCT04964323 Terminated Pyruvate Kinase (PK) Deficiency Global Longitudinal Registry: Patient-Reported Outcomes (PRO) July 2, 2021 June 30, 2023
NCT01975844 Terminated Phase 4 The Effect of Epogen and Venofer Dosing Management on Hemoglobin Stability July 2013
NCT00210626 Terminated Phase 2 Assess Functional Outcomes in Anemic, Critically Ill, Trauma Patients When Taking Epoetin Alfa August 2005 June 2008
NCT00576602 Terminated Phase 4 A Study of Subcutaneous Mircera, Versus no Erythropoiesis-Stimulating Agent (ESA) Therapy, in the Treatment of Anemia in Patients With Chronic Kidney Disease After Kidney Transplant December 2007 July 2008
NCT00588146 Terminated Phase 2 Phase 2 Study of PEG-Intron in Hereditary Hemorrhagic Telangiectasia January 2007 September 2011
NCT00211120 Terminated Phase 4 Correction of Hemoglobin and Outcomes in Renal Insufficiency (CHOIR) March 2002 August 2005
NCT02075463 Terminated Phase 2 Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia June 1, 2014 March 16, 2016
NCT05118048 Terminated StatStrip Lactate, Hemoglobin, and Hematocrit Meter in Whole Blood January 18, 2021 October 22, 2021
NCT00629876 Terminated Phase 1 A Safety and Tolerability Study of Peginesatide in Anemic Cancer Patients Receiving Cytotoxic Chemotherapy. January 2008 June 2008
NCT00119600 Terminated Phase 1/Phase 2 A Study of AMG 114 Administered by Subcutaneous Injection for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy
NCT05178342 Terminated Phase 2 Treatment of Anemia in Patients With Very Low, Low or Intermediate Risk Myelodysplastic Syndromes With CA-4948 January 1, 2022 March 6, 2024
NCT00109291 Terminated Phase 2 Safety of Single Doses of Peginesatide in Patients With Chronic Kidney Disease March 2005 February 2006
NCT00664066 Terminated DELFT (Dynepo Evaluation of Long-Term Follow-Up Treatment) April 25, 2008 July 30, 2008
NCT02189889 Terminated Phase 1/Phase 2 Active Preoperative Anemia Management in Patients Undergoing Cardiac Surgery April 9, 2013 July 26, 2019
NCT00680563 Terminated Phase 3 A Study of Once-Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Pre-Dialysis Patients Not Currently Treated With ESA. April 2009 January 2010
NCT00695396 Terminated Phase 3 A Study Evaluating Epoetin Alfa 40,000 IU (International Units) Every Week or 80,000 IU Every Week Compared to Placebo in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes at Risk for Transfusion June 2008 January 2010
NCT00701714 Terminated Phase 3 Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis Patients September 2007 January 2010
NCT00702702 Terminated Phase 3 Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids June 2008 August 2009
NCT05237713 Terminated Phase 2 Efficacy and Safety of Canakinumab for the Treatment of Anemia in LR-MDS Patients April 26, 2022 February 29, 2024
NCT03782623 Terminated Effect of Packed Red Blood Cell Transfusion on Eicosanoid Profiles in Plasma of Intensive Care Patients December 1, 2018 December 31, 2022
NCT00210002 Terminated Phase 2 Evaluation of Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-Induced November 2003 April 2006
NCT02333136 Terminated In Vivo Raman Spectroscopy of Human Capillary Beds August 2012 January 1, 2024
NCT00194857 Terminated Phase 4 Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and Ribavirin February 2002 December 2005
NCT00785356 Terminated Phase 3 Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids October 2008 August 2009
NCT00801931 Terminated Phase 1/Phase 2 Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders September 6, 2007 May 5, 2009
NCT00189371 Terminated Phase 3 Reinduction Chemotherapy Containing Carboplatin and Paclitaxel With or Without Epoetin Alpha in Recurrent Platinum Sensitive Ovarian Cancer, Cancer of the Fallopian Tube or Peritoneum February 2004 December 2005
NCT00236405 Terminated Phase 2 PROCRIT and Short-Term Outcomes in Orthopedic Surgery March 2005 October 2005
NCT00858364 Terminated Phase 3 Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy July 17, 2009 June 7, 2017
NCT00875004 Terminated N/A Epoetin Beta in Patients Undergoing Chemotherapy for Solid Tumors December 7, 2007 December 31, 2011
NCT00907608 Terminated N/A A Proof-of-Concept Study of Darbepoetin Alfa in Partial Correction of Anemia in Chinese With Diabetic Nephropathy December 2007 May 2009
NCT02564796 Terminated Phase 2 Erythropoietin to Prevent Unnecessary Transfusions In Patients With Cyanotic CHD - A Prospective Control Trial November 2016 June 2020
NCT03878524 Terminated Phase 1 Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial April 1, 2020 December 10, 2020
NCT00924781 Terminated Phase 2 A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease (MK2578-003-AM03-EXT12) June 2009 May 2010
NCT00968617 Terminated Phase 2 A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis (2578-002) November 2009 May 2010
NCT02608060 Terminated Phase 4 A Study to Assess the Hematopoyetic Response of Anemic Patients With Hematologic Malignancies Treated With Erythropoietin B September 2006 October 2007
NCT00989092 Terminated Phase 2 Darbepoetin Alfa and Anemia of Cancer May 2002 June 2004
NCT02624141 Terminated Phase 4 A Study of Recormon (Epoetin Beta) in Anemic Patients With Non-Myeloid Malignancy April 2006 December 2009
NCT03933813 Terminated Phase 1/Phase 2 Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients July 29, 2019 November 22, 2021
NCT02630927 Terminated Phase 1 A Safety and Tolerability Study of AG-519 in Healthy Subjects December 2015 December 2016
NCT01018576 Terminated N/A Delayed Cord Clamping in Premature Infants September 2009 March 2012
NCT01034592 Terminated Phase 1 Pilot Lenalidomide in Adult Diamond-Blackfan Anemia Patients w/ RBC Transfusion-Dependent Anemia November 2009 December 2012
NCT00104169 Terminated Phase 2 Idiopathic Anemia of Aging (IAA) August 2004 May 2007
NCT01066000 Terminated Phase 4 A Study for Monthly Methoxy Polyethylene Glycol-Epoetin Beta Treatment in Patients With Chronic Renal Anaemia October 31, 2009 September 30, 2011
NCT04080908 Terminated Phase 4 Study to Assess Feasibility and Safety of Iron Repletion With Feraheme in Iron Deficient Patients With Durable Ventricular Assist Device Support January 15, 2020 October 19, 2021
NCT02730884 Terminated Phase 2 Single-Arm Study of the Efficacy and Safety of Oral Rigosertib in Patients With Myelofibrosis (MF) and Anemia August 16, 2017 August 22, 2019
NCT04208451 Terminated N/A The Effects of One Month Consumption of Standardized Aronia Melanocarpa Extract on Anemia in Patients on Hemodialysis August 1, 2019 October 1, 2019
NCT04233944 Terminated Uganda Birth Cohort Study November 15, 2014 November 4, 2016
NCT00083486 Terminated Phase 3 Treatment of Anemia in Patients With Cancer Who Are Not Currently Receiving Chemotherapy or Radiotherapy February 2004 October 2004
NCT01284348 Terminated Phase 2 To Determine Safe and Effective Dose of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Participants With Advanced Non-small Cell Lung Cancer March 25, 2011 September 21, 2012
NCT01290328 Terminated N/A Study of Epoetin Alfa to Treat Anemia After Kidney Transplantation February 2011 April 2014
NCT01309659 Terminated Phase 2 Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia May 2011 September 2014
NCT00236678 Terminated Phase 2 Randomized, Double-blind, Placebo-controlled Study to Assess Fatigue in Patients With ACD Due to RA Receiving PROCRIT July 2004 January 2006
NCT01825226 Unknown status N/A Helen Keller International's Enhanced-Homestead Food Production Program in Burkina Faso February 2010 September 2017
NCT02128971 Unknown status Phase 2 A Study to Compare the Gastrointestinal Tolerability of Ferrochel®, Sumalate®,Ferrous Fumarate, Ferrous Sulfate, Ferric Glycinate, and Placebo April 2014 August 2014
NCT01459146 Unknown status Phase 4 Artemisinin-based Combination Therapy-Intermittent Preventive Treatment (ACT-IPT) Trial Among Schoolchildren in Kassena-Nankana, Ghana December 2010 November 2012
NCT00482716 Unknown status Phase 3 Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer January 2007
NCT03909711 Unknown status Relationship Between Temperature and Intraoperative Bleeding in Patients Undergoing Multilevel Spinal Surgery May 15, 2019 November 2019
NCT02939794 Unknown status Phase 4 The Effect of Ferric Carboxymaltose on Hemoglobin and Blood Transfusion in Cardiac Surgery November 2016 August 2019
NCT01917851 Unknown status Evaluate the Accuracy of the NBM200 for Noninvasive Hemoglobin Measurements on Obstetric/Gynecological Patients April 2011 December 2013
NCT00436202 Unknown status N/A Evaluation of an Intervention Program for the Prevention of Anemia
NCT02874326 Unknown status Phase 2 Octreotide in Patients With GI Bleeding Due to Rendu-Osler-Weber October 2016 October 2018
NCT01541631 Unknown status N/A A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment Outcomes May 2012 June 2013
NCT02619097 Unknown status Phase 1 Safety & Pharmacokinetics of Pegolsihematide for Treatment of Anemia Patient With Myelodysplastic Syndromes June 2014 March 2016
NCT01927328 Unknown status Phase 4 Iron Replacement in Oesophagogastric Neoplasia August 2013 August 2017
NCT04491916 Unknown status N/A Iron Therapy in Patients With End-Stage Renal Disease April 1, 2020 December 31, 2022
NCT00173706 Unknown status Phase 4 Evaluation of the Effects of L-Carnitine Injection in Patients Undergoing Hemodialysis October 2004
NCT03359447 Unknown status Phase 4 Iron Deficiency Anemia, Iron Supplementation and Genomic Stability in Infants August 1, 2017 August 1, 2019
NCT04883567 Unknown status The Use of AI to Improve Quality of OGD May 1, 2021 June 30, 2022
NCT04464850 Unknown status Phase 3 Intravenous Versus Oral Iron Therapy in Hemodialysis Patients July 29, 2020 July 31, 2022
NCT00413816 Unknown status The Israeli Trigger for Blood Transfusions in the ICU October 2006 December 2006
NCT03397901 Unknown status N/A Transverse Colostomy for Refractory Hemorrhagic Chronic Radiation Proctitis: a Prospective Cohort Study July 20, 2018 December 2022
NCT03295851 Unknown status Phase 4 Preoperative Intravenous Iron Infusion to Reduce Post-surgical Complications: a Pilot Randomised Control Trial November 22, 2017 March 2019
NCT03287882 Unknown status Phase 3 Effect of Micronutrients and Life Skills Education on the Health and Nutrition of Adolescent and Young Women in Pakistan June 30, 2017 February 2022
NCT03450174 Unknown status N/A Effectiveness of Multiple Micro-nutrient Fortified Fudge on Nutritional Status of 3-5 Years of Age Children October 2, 2017 August 30, 2018
NCT03455257 Unknown status N/A Evaluation of a Cash Transfer Program in Low-Income Families in Guinea-Bissau April 25, 2017 December 2020
NCT02031614 Unknown status N/A The Immunomodulatory Effects of Phlebotomy January 2014 May 2014
NCT00039884 Unknown status Phase 2 Will Radiation/Chemotherapy Treatment of Cervical Cancer Work Better With Medication That May Improve Anemia? September 2001 March 2003
NCT00248716 Unknown status Phase 4 Treatment of Anemia in the 2nd Year of Life. Comparison of the Efficacy of Two Different Iron Preparations. February 2007
NCT01017627 Unknown status N/A Impact of Adherence to Anemia Management Policy on Repeat Hospitalization in End Stage Renal Disease (ESRD) November 2009 December 2010
NCT04622449 Unknown status Etiopathogenesis of Anemia in Chronic Liver Disease September 1, 2020 December 31, 2021
NCT04857450 Unknown status N/A Anesthesia for Upper Endoscopy and Colonoscopy in Cardiac Patients With Acute Anemia November 20, 2020 December 20, 2021
NCT03497416 Unknown status Impact of Preoperative Anemia on Healthcare Outcomes October 3, 2017 October 2019
NCT04263571 Unknown status Hepcidin as a Predictor for the IVI Mediated Increase in Haemoglobin Levels April 12, 2019 December 31, 2023
NCT04840225 Unknown status Anemia in Patients With Endocarditis March 22, 2021 December 1, 2023
NCT00148629 Unknown status Phase 3 Treatment and Prevention of Severe Anemia in Pregnant Zanzibari Women April 2004
NCT01025011 Unknown status Non-invasive Measurement of Hemoglobin in Retinal Arteries March 2008 June 2010
NCT00386126 Unknown status Phase 2/Phase 3 Iron Supplementation in Heart Failure Patients With Anemia: The IRON-HF Study August 2006
NCT02646410 Unknown status N/A Optimization of Seasonal Malaria Chemoprevention (SMC) Delivery August 2014 December 2018
NCT02102321 Unknown status N/A Does Treating Hookworm Improve Productivity of Small Subsistence Farmers March 2014 August 2015
NCT03005847 Unknown status N/A The Effect of Fermented Papaya Preparation on Patients With Chronic Kidney Disease Under Dialysis Receiving Intravenous Iron March 2017
NCT03638557 Unknown status N/A School Lunch Program (SLP) Towards Nutrition Knowledge, Attitude, Practices and Nutrition Status of Adolescents January 26, 2018 March 2019
NCT03640403 Unknown status Phase 3 Effectiveness and Safety of Intermittent Preventive Treatment for Malaria Using Either Dihydroartemisinin-piperaquine or Artesunate-amodiaquine in Reducing Malaria Related Morbidities and Improving Cognitive Ability in School-aged Children in Tanzania March 26, 2019 December 31, 2021
NCT04757909 Unknown status N/A Detection of Anemizations in Primary Care. March 30, 2017 December 2023
NCT00152204 Unknown status Phase 3 The Community Effectiveness of IPTi in Southern Tanzania March 2005 December 2008
NCT03176719 Unknown status Non-specific Effects of Vaccination on Mortality and Morbidity June 17, 2017 December 31, 2018
NCT00675337 Unknown status N/A Effect of Infant Placement on Iron Stores in Infancy: A Pilot Study June 2008 April 2009
NCT02851472 Unknown status Phase 1/Phase 2 Prevention of Transfusion Related Acute Gut Injury (TRAGI) in Extremely Low Gestational Age Neonates (ELGANs) Using iNO February 6, 2019 June 30, 2021
NCT05221957 Unknown status N/A Effects of Preoperative Correction of Anemia With Intravenously Iron in Colorectal Cancer Patients. March 1, 2022 December 2023
NCT01039051 Unknown status Phase 2/Phase 3 Diet and Lifestyle Intervention Study in Postpartum Women in China June 2009 June 2010
NCT03138200 Unknown status N/A The Role of Central Venous Oxygen Saturation (ScvO2) as an Indicator of Blood Transfusion in the Critically Ill March 8, 2017 March 1, 2019
NCT04484233 Unknown status Evaluation of a Clinical Decision Support System for Anemia Management in Pre-operative Care September 1, 2020 December 31, 2020
NCT02662699 Unknown status Clinical Signs and Symptoms of Anemia in Patients Over 75 Years October 2016 January 2018
NCT00168948 Unknown status Phase 4 Intermittent Antimalaria Treatment With SP in African Children March 2003 August 2005
NCT04708665 Unknown status Iron Deficiency Anemia and Non-iron Deficiency Anemia in Pregnancy in India November 23, 2020 January 31, 2022
NCT00337441 Unknown status Phase 2 Treatment of Chronic Anemia With Epoetin Alfa in Elderly January 2003 July 2005
NCT02243735 Unknown status Phase 4 Trial Comparing Ferric(III)Carboxymaltose Infusion With Oral Iron Suppletion as Treatment of Anaemia November 2014 December 2019
NCT00247507 Unknown status Phase 4 The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients September 2005 December 2005
NCT05280795 Unknown status Audit on Anemia Variation After Major Gynacological Surgery December 1, 2021 July 1, 2023
NCT03805139 Unknown status N/A Role of Ajwa Derived Polyphenols in Dyslipidaemias March 20, 2019 December 7, 2019
NCT03805776 Unknown status N/A Intermittent Fasting in Dyslipidemia February 20, 2019 September 15, 2019
NCT02312414 Unknown status N/A Effects of Carnitine on Oxidative Stress to IVIR Administration to CKD Patients:Impact of Haptoglobin Genotype October 2014
NCT00003681 Unknown status Phase 2 Amifostine With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome August 1998
NCT02337335 Unknown status Assesment of a Predictive Model Dosage of EPO in Hemodialysis Patients November 2014 April 2015
NCT02366325 Unknown status Phase 2 Safety & Efficacy of EPO-018B for the Treatment of Anemia in Participants With ERSD Receiving Maintenance Hemodialysis July 2014 December 2015
NCT01648946 Unknown status Phase 3 Transfusion Requirements in Critically Ill Oncologic Patient June 2012 June 2013
NCT02385383 Unknown status An Intravenous Iron Based Protocol for Preoperative Anaemia in Hip and Knee Surgery - An Observational Study October 2014 February 2017
NCT02385409 Unknown status Incidence and Reasons for Preoperative Anemia in Elective Lower Joint Arthroplasty May 2013 May 2015
NCT05356325 Unknown status FGF23 and Cardiovascular Damage in Anemia With an Without Chronic Kidney Disease. October 18, 2021 June 2023
NCT02403362 Unknown status Phase 2 Safety & Efficacy of EPO-018B for the Treatment of Anemia in Participants With Chronic Kidney Diseases Not on Dialysis June 2014 October 2015
NCT02860598 Unknown status Observatory of the Prescription of Erythropoietin as Treatment of Anemia Induced by Chemotherapy or Allograft Conditioning Among the Patients With a Haematological Malignancy December 2011 June 2019
NCT02428868 Unknown status N/A IV Iron in Association With Tranexamic Acid for Hip Fracture April 2015 April 2016
NCT03837171 Unknown status Phase 3 TRANSfusion in Patients With Onco-hematological Malignancies ResusciTated From Septic Shock March 24, 2019 February 20, 2022
NCT01632761 Unknown status N/A Effects of Vitamin D and Marine Omega-3 Fatty Acids on Anemia November 2012 June 2019
NCT04642521 Unknown status Association Between Anaemia and Handgrip Strength in Female Planned for Major Surgery and the Effect of Intravenous Iron on Handgrip Strength November 18, 2020 April 30, 2021
NCT00303784 Unknown status Phase 3 Prostate Adenocarcinoma TransCutaneous Hormones March 2006 August 2021
NCT02741648 Unknown status RBC Irradiation, Anemia and Gut Injury July 2016 April 2022
NCT04097639 Unknown status Inflammation, Iron Deficiency and Anaemia Study 1 May 7, 2019 November 2021
NCT02760940 Unknown status Phase 4 Anemia in Inflammatory Bowel Disease August 2016 August 2018
NCT03019900 Unknown status Survey of Blood Transfusion Practices in Critically Ill Patients at High Altitude February 2017 April 2017
NCT03871244 Unknown status Phase 3 Pilot Optimizing Transfusion Thresholds in Critically-ill Children With Anaemia June 3, 2020 December 31, 2022
NCT03876704 Unknown status Phase 3 Effects of Fat-soluble Vitamins Supplementation on Common Complications and Neural Development in Very Low Birth Weight Infants January 29, 2019 December 31, 2020
NCT04101240 Unknown status Anemia and Red Blood Cells Transfusion in Oncological Surgery February 7, 2019 November 30, 2019
NCT02959125 Unknown status N/A NutFish and Nutrient Supplementation in Pregnancy Class to Improve Maternal and Birth Outcomes December 12, 2016 December 20, 2017
NCT04505514 Unknown status Phase 4 Single Dose Intravenous Iron Isomaltoside in Combination With Oral Iron vs Oral Iron Monotherapy in Patients With Anemia After Postpartum Haemorrhage August 1, 2020 December 31, 2022
NCT03895164 Unknown status N/A Linear Programming Approach to Develop Local Specific Food-based Complementary Feeding Recommendation December 19, 2018 December 31, 2019
NCT04502784 Unknown status Investigation of Hypophosphataemia Following Intravenous Iron October 7, 2019 December 31, 2020
NCT01579110 Unknown status Phase 2 Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic Anemia. April 2012 April 2016
NCT04910594 Unknown status Phase 3 Clinical Study the Efficacy and Safety of Rh-EPO in the Treatment of Anemia in Lymphoma April 1, 2021 April 1, 2023
NCT01881503 Unknown status N/A Expanded Access Study of HBOC-201 (Hemopure) for the Treatment of Life-Threatening Anemia October 2013 December 2023
NCT00926406 Unknown status N/A Environmental Exposure to Lead and Its Health Effects on Patients With Maintenance Hemodialysis April 2010 December 2011
NCT02586402 Unknown status Phase 2 Safety & Efficacy of Pegolsihematide for Treatment of Anemia in Participants on Dialysis October 2015 August 2016
NCT03010579 Unknown status Phase 4 Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation October 2016 December 2018
NCT02599012 Unknown status Phase 2 The Efficacy of Intravenous Iron for the Treatment of Anemia in Cancer Patients September 12, 2015 December 2017
NCT01864395 Unknown status N/A Clinical and Chemical Outcomes Following Cardiac Surgery: The Post-Operative Effects of MUF July 2013 October 2014
NCT01915953 Unknown status A Clinical Evaluation of the OrSense Non-invasive Blood Hb/Hct Measurement Instrument, the Hemo-Monitor NBM200/MP February 2011 December 2013
NCT01917487 Unknown status A Trial to Evaluate the Precision and Accuracy of the NBM-200 Series When Used in a Continuous Prospective Mode November 2011 November 2013
NCT00479102 Unknown status Phase 4 Prevention of Iron Deficiency in 2nd Year of Life May 2007
NCT00371228 Withdrawn N/A Timing of Cord Clamping and Neonatal Hemoglobin September 2006 June 2009
NCT04815603 Withdrawn Phase 2 Study to Evaluate Efficacy and Safety of BGE-117 in the Treatment of Anemia of Aging March 22, 2021 April 2022
NCT00560547 Withdrawn Phase 3 A Study of Once-Monthly Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia. October 2007 October 2009
NCT00954486 Withdrawn N/A Erythropoietin Alfa in Elderly Subjects With Unexplained Anemia December 2008 February 2011
NCT00609544 Withdrawn Phase 2 Study of the Safety and Effectiveness of Rilonacept (IL-1 Trap) Administered Subcutaneously in Subjects With Non Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) and Anemia
NCT01724073 Withdrawn N/A Regular Consumption of Leafy Vegetable Sauces and Micro-nutrient Status of Young Children in Burkina Faso December 2012 August 2013
NCT03056378 Withdrawn Phase 1 POOLED Red Blood Cells Prepared From Pooling 5 Leukoreduced, Irradiated RBC Units October 2019 June 2021
NCT03573570 Withdrawn N/A Reducing Anemia Through Food Fortification at Scale April 1, 2018 September 30, 2021
NCT03486054 Withdrawn N/A INTERCEPT Safety Evaluation in Anemic Patients June 2019 June 2020
NCT00384657 Withdrawn Phase 3 Intravenous Iron in Patients With Severe Chronic Heart Failure and Chronic Kidney Disease January 2008 December 2017
NCT01435746 Withdrawn N/A Transfusion Requirements After Orthotopic Liver Transplantation November 2011 November 2013
NCT04320966 Withdrawn Neurovascular Complications and White Matter Damage in Acquired Anemias November 1, 2020 November 1, 2020
NCT04921696 Withdrawn Association of Red Blood Cell Transfusion, Anemia, and Necrotizing Enterocolitis July 1, 2021 December 31, 2026
NCT01701531 Withdrawn Phase 2/Phase 3 Red Blood Cell Precursor Formulation to Determine Increased Production October 2012 May 2014
NCT00446602 Withdrawn Phase 2 A Phase 2 Study to Evaluate the Safety and Effectiveness of Once Weekly or Once Every Two Week Dosing of Epoetin Alfa in Anemic Patients With Low- or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) August 2009
NCT01786408 Withdrawn N/A A Study to Compare Analytes in Blood Collected Using an Investigational Collection Device With a Commercial Predicate March 2013 March 2013
NCT00579046 Withdrawn Phase 3 Study of Erythropoietin to Treat Anemia Complicating Chronic Obstructive Pulmonary Disease November 2008 October 2009
NCT01428154 Withdrawn Phase 1 Study to Evaluate Darbepoetin Alfa in Pediatric Subjects With Anemia Due to Chronic Kidney Disease April 2016 November 2016
NCT01837030 Withdrawn N/A Capsule Endoscopy Versus Conservative Therapy for Obscure Gastrointestinal Bleeding March 2013 March 2013
NCT00459225 Withdrawn N/A Iron Prophylaxis for Anemia in Infants With Cyanotic Congenital Heart Disease April 2007 June 2013
NCT00869856 Withdrawn Phase 3 Study to Evaluate the Efficacy, Safety and Immunogenicity of Subcutaneous HX575 in the Treatment of Anemia Associated With Chronic Kidney Disease (SWEEP) April 2009 August 2009
NCT00123149 Withdrawn Phase 2 Open-Label Extension Safety Study of PROCRIT in Patients With Anemia of Chronic Disease Due to Rheumatoid Arthritis October 2007
NCT03086252 Withdrawn N/A Patient-Driven Transfusion Thresholds in Hematological Disorders: A Pilot Study July 24, 2017 May 31, 2018
NCT02047552 Withdrawn Phase 2 RCT of Goal-directed Iron Supplementation of Anemic, Critically Ill Trauma Patients, With and Without Oxandrolone January 2015 December 2017
NCT03073369 Withdrawn Phase 4 Effect of Ergocalciferol on Iron Metabolism in Individuals With Chronic Kidney Disease January 1, 2018 December 2018
NCT01934842 Withdrawn N/A A Study to Compare Analyte Levels in Blood Collected Using an Investigational Collection Device With a Commercial Predicate September 2013 September 2013
NCT03873584 Withdrawn Improvement of Fatigue Symptoms in the Iron Deficiency Anemia With Iron Succinylate Therapy September 1, 2022 September 30, 2023
NCT00269971 Withdrawn Phase 3 A Study to Determine an Effective Dose of Epoetin Alfa to Decrease the Number of Units of Blood Required to be Transfused During Hip Replacement Surgery. May 1996 April 1999
NCT03242967 Withdrawn Phase 3 Study to Evaluate Three Times Per Week (TIW) Oral Dosing of Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) August 2017 February 12, 2018
NCT02926651 Withdrawn Phase 4 Single Versus Multi-Dose Oral Tranexamic Acid in Patients at High Risk for Blood Transfusion After Total Joint Arthroplasty October 2016 July 2017
NCT00915317 Withdrawn Effect of Vitamin D Supplementation on Erythropoietin Dosage in Hemodialysis Patients Who Have Vitamin D Deficiency October 2008 March 2009
NCT00210977 Withdrawn A Study of Patients Treated With Erythropoietin Receptor Agonists for Anemia Who Developed Anti-erythropoietin Antibodies December 2005 January 2010
NCT01660347 Withdrawn N/A Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant August 2012 December 2014
NCT00481624 Withdrawn Phase 2 Using Iron With Procrit in Advanced Lung Cancer Patients With Chemotherapy-Induced Anemia May 2007 November 2009
NCT00301912 Withdrawn Phase 2 Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer January 2002
Disase is a (Disease Ontology)
DOID:74
Cross Reference ID (Disease Ontology)
EFO:0004272
Cross Reference ID (Disease Ontology)
ICD10CM:D64.9
Cross Reference ID (Disease Ontology)
ICD9CM:285.9
Cross Reference ID (Disease Ontology)
MESH:D000740
Cross Reference ID (Disease Ontology)
NCI:C2869
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:64593003
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0002871
Exact Synonym (Disease Ontology)
anaemia
HPO alt_id (Human Phenotype Ontology)
HP:0001926
HPO alt_id (Human Phenotype Ontology)
HP:0003136
HPO alt_id (Human Phenotype Ontology)
HP:0005509
HPO Human Phenotype ID (Human Phenotype Ontology)
HP:0001903
MeSH unique ID (MeSH (Medical Subject Headings))
D000740